TW201632585A - Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent - Google Patents

Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent Download PDF

Info

Publication number
TW201632585A
TW201632585A TW104107577A TW104107577A TW201632585A TW 201632585 A TW201632585 A TW 201632585A TW 104107577 A TW104107577 A TW 104107577A TW 104107577 A TW104107577 A TW 104107577A TW 201632585 A TW201632585 A TW 201632585A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
formula
compound
Prior art date
Application number
TW104107577A
Other languages
Chinese (zh)
Other versions
TWI563036B (en
Inventor
邱信融
黃菀婷
蔡宗沛
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW104107577A priority Critical patent/TWI563036B/en
Priority to CN201610133685.6A priority patent/CN105969404B/en
Publication of TW201632585A publication Critical patent/TW201632585A/en
Application granted granted Critical
Publication of TWI563036B publication Critical patent/TWI563036B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133719Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films with coupling agent molecules, e.g. silane
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

A liquid crystal alignment agent contains a polymer composition, a polysiloxane, and a solvent. The polymer composition is obtained by subjecting a mixture including a tetracarboxylic dianhydride component and a diamine component to a reaction. The diamine component includes first and second diamine compounds defined herein. The polysiloxane obtained by subjecting a polysiloxane compound containing an epoxy-based group and a carboxylic acid compound having a C4-C50 chain to a reaction. A liquid crystal display element made from the aforesaid liquid crystal alignment agent has reduced ion density.

Description

液晶配向劑及由該液晶配向劑形成的液晶配 向膜及液晶顯示元件 Liquid crystal alignment agent and liquid crystal matching formed by the liquid crystal alignment agent Film and liquid crystal display element

本發明是有關於一種液晶配向劑,特別是指一種用於形成紫外線可靠度佳的液晶配向膜的液晶配向劑。本發明還關於一種由該液晶配向劑形成的液晶配向膜,及包含該液晶配向膜的液晶顯示元件。 The present invention relates to a liquid crystal alignment agent, and more particularly to a liquid crystal alignment agent for forming a liquid crystal alignment film having excellent ultraviolet light reliability. The present invention also relates to a liquid crystal alignment film formed of the liquid crystal alignment agent, and a liquid crystal display element comprising the liquid crystal alignment film.

近年來由於對液晶顯示器的顯示品質要求逐年提升,使得液晶顯示元件需朝向高性能化發展,繼而從TN、STN發展至IPS、VA、PSA等類型之液晶顯示器。基於不同顯示原理,各種液晶顯示器中之液晶所需之預傾角亦不相同。然而,為了具有較佳的顯示品質,共同需求為良好的液晶配向性,因此,液晶配向劑之配向性便成為影響液晶顯示元件特性的重要研究對象之一。 In recent years, as the display quality requirements for liquid crystal displays have been increasing year by year, liquid crystal display elements have to be developed toward high performance, and then developed from TN and STN to liquid crystal displays of the IPS, VA, PSA and the like. Based on different display principles, the pretilt angles required for liquid crystals in various liquid crystal displays are also different. However, in order to have a better display quality, the common demand is a good liquid crystal alignment property, and therefore, the alignment property of the liquid crystal alignment agent becomes one of important research objects that affect the characteristics of the liquid crystal display element.

日本特開平9-176651掲示一種預傾角安定性佳之液晶配向膜。該液晶配向劑包含一聚合物,是由含膽固 醇(steroid)骨格之二胺化合物與含膽固醇骨格之四羧酸二酐化合物經聚合反應而得。上述液晶配向膜可於高溫下仍維持一定之預傾角而達到良好的液晶配向性。然而,該液晶配向劑仍有紫外線可靠度低之問題,而無法為業者所接受。 Japanese Patent Laid-Open No. 9-176651 shows a liquid crystal alignment film having a good pretilt stability. The liquid crystal alignment agent comprises a polymer and is composed of a cholesterol-containing A diamine compound of a steroid skeleton is obtained by polymerization of a tetracarboxylic dianhydride compound containing a cholesterol skeleton. The above liquid crystal alignment film can maintain a certain pretilt angle at a high temperature to achieve good liquid crystal alignment. However, the liquid crystal alignment agent still has a problem of low ultraviolet reliability and is not acceptable to the industry.

本領域對於能形成具有優越紫外線可靠度的液晶配向膜的液晶配向劑的需求上升。 There is an increasing demand in the art for a liquid crystal alignment agent capable of forming a liquid crystal alignment film having superior ultraviolet reliability.

因此,本發明之第一目的,即在提供一種用於形成具有優越紫外線可靠度的液晶配向膜的液晶配向劑。 Accordingly, a first object of the present invention is to provide a liquid crystal alignment agent for forming a liquid crystal alignment film having superior ultraviolet reliability.

於是,本發明液晶配向劑,包含一聚合物組成物、一聚矽氧烷,及一溶劑。該聚合物組成物是由將四羧酸二酐組份及二胺組份進行反應所製得。該二胺組份包括一式(I)所示的第一二胺化合物: Thus, the liquid crystal alignment agent of the present invention comprises a polymer composition, a polyoxyalkylene oxide, and a solvent. The polymer composition is obtained by reacting a tetracarboxylic dianhydride component and a diamine component. The diamine component comprises a first diamine compound of formula (I):

其中 R12及R14是獨立地選自於-O-、-S-、 R13表示一C2至C10的亞烷基,R11是選自於單鍵、亞甲基、伸乙基,及X表示一C17至C40具有膽固醇骨架的一價有機基團;一式(II)所示的第二二胺化合物: Wherein R 12 and R 14 are independently selected from -O-, -S-, , R 13 represents a C 2 to C 10 alkylene group, R 11 is a monovalent organic group selected from the group consisting of a single bond, a methylene group, an extended ethyl group, and X represents a C 17 to C 40 having a cholesterol skeleton; a second diamine compound of formula (II):

其中 R15是選自於-O-、 ,及,及R16表示一如式(II-1)所示的有機基團: Wherein R 15 is selected from -O-, , , , ,and And R 16 represents an organic group as shown in formula (II-1):

其中R17是各自獨立地表示氫、氟或甲基;R18、R19或R20 是各自獨立地表示單鍵、-O-、或C1至C3的伸烷基; R21是各自獨立地選自於,其中R23及R24是各自獨立地表示氫、氟或甲基,R22是選自於氫、氟、C1至C12的烷基、C1至C12的氟烷基、C1至C12的烷氧基、-OCH2F、-OCHF2及-OCF3;k表示1或2的整數,l、m及n是各自獨立地表示0至4的整數,o、p及q是各自獨立地表示0至3的整數,且條件是 o+p+q≧3,及r及s是各自獨立地表示1或2;其中該聚矽氧烷是由將一含有環氧基基團的聚矽氧烷化合物及一具有C4-C50之側鏈的羧酸化合物進行反應所製得。 Wherein R 17 each independently represents hydrogen, fluorine or methyl; and R 18 , R 19 or R 20 each independently represent a single bond, -O-, , , , , Or a C 1 to C 3 alkylene group; R 21 are each independently selected from and Wherein R 23 and R 24 each independently represent hydrogen, fluorine or methyl, and R 22 is selected from hydrogen, fluorine, C 1 to C 12 alkyl, C 1 to C 12 fluoroalkyl, C 1 Alkoxy group to C 12 , -OCH 2 F, -OCHF 2 and -OCF 3 ; k represents an integer of 1 or 2, and l, m and n are integers each independently representing 0 to 4, o, p and q Is an integer which independently represents 0 to 3, and the condition is o+p+q≧3, and r and s each independently represent 1 or 2; wherein the polyoxyalkylene is composed of an epoxy group-containing group The polyoxyalkylene compound of the group is reacted with a carboxylic acid compound having a side chain of C 4 - C 50 to carry out a reaction.

本發明之第二目的,即在提供一種由該液晶配向劑形成的具有優越紫外線可靠度的液晶配向膜。 A second object of the present invention is to provide a liquid crystal alignment film having superior ultraviolet reliability which is formed of the liquid crystal alignment agent.

於是,本發明液晶配向膜,是由如前所述的液晶配向劑所形成。 Thus, the liquid crystal alignment film of the present invention is formed by the liquid crystal alignment agent as described above.

本發明之第三目的,即在提供一種包含該液晶配向膜的液晶顯示元件,且具有較佳的紫外線可靠度。 A third object of the present invention is to provide a liquid crystal display element comprising the liquid crystal alignment film and having better ultraviolet reliability.

於是,本發明液晶顯示元件,是包含如前所述的液晶配向膜。 Thus, the liquid crystal display element of the present invention comprises a liquid crystal alignment film as described above.

本發明的功效在於:透過同時使用包括式(I)及式(II)所示的第一及第二二胺化合物的二胺組份及由該含有環氧基基團的聚矽氧烷化合物及該具有C4-C50之側鏈的羧酸化合物進行反應所製得的聚矽氧烷,使該液晶配向劑所形成的液晶配向膜具有較佳的紫外線可靠度。 The effect of the present invention resides in that the diamine component comprising the first and second diamine compounds represented by the formula (I) and the formula (II) and the polyoxyalkylene compound containing the epoxy group are simultaneously used. The polyoxyalkylene obtained by reacting the carboxylic acid compound having a side chain of C 4 - C 50 causes the liquid crystal alignment film formed by the liquid crystal alignment agent to have better ultraviolet reliability.

11‧‧‧第一單元 11‧‧‧ first unit

111‧‧‧第一基板 111‧‧‧First substrate

112‧‧‧第一導電膜 112‧‧‧First conductive film

113‧‧‧第一液晶配向膜 113‧‧‧First liquid crystal alignment film

12‧‧‧第二單元 12‧‧‧Second unit

121‧‧‧第二基板 121‧‧‧second substrate

122‧‧‧第二導電膜 122‧‧‧Second conductive film

123‧‧‧第二液晶配向膜 123‧‧‧Second liquid crystal alignment film

13‧‧‧液晶單元 13‧‧‧Liquid Crystal Unit

本發明之其他的特徵及功效,將於參照圖式的實施方式中清楚地呈現,其中:圖1是一局部示意圖,說明本發明液晶顯示元件的一個實施例。 Other features and advantages of the present invention will be apparent from the description of the embodiments of the present invention. FIG. 1 is a partial schematic diagram illustrating an embodiment of a liquid crystal display element of the present invention.

液晶配向劑Liquid crystal alignment agent

本發明液晶配向劑,包含一聚合物組成物、一聚矽氧烷,及一溶劑。 The liquid crystal alignment agent of the present invention comprises a polymer composition, a polyoxyalkylene oxide, and a solvent.

聚合物組成物Polymer composition

該聚合物組成物是由將四羧酸二酐組份及二胺組份進行反應所製得。 The polymer composition is obtained by reacting a tetracarboxylic dianhydride component and a diamine component.

四羧酸二酐Tetracarboxylic dianhydride

所述四羧酸二酐組份指的是該組份包含至少一種四羧酸二酐化合物。該四羧酸二酐化合物是選自於脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物,或具有式(A-1)至(A-6)結構的四羧酸二酐化合物,或前述之一組合。 The tetracarboxylic dianhydride component means that the component contains at least one tetracarboxylic dianhydride compound. The tetracarboxylic dianhydride compound is selected from the group consisting of an aliphatic tetracarboxylic dianhydride compound, an alicyclic tetracarboxylic dianhydride compound, an aromatic tetracarboxylic dianhydride compound, or has the formula (A-1) to (A). -6) a structural tetracarboxylic dianhydride compound, or a combination of the foregoing.

其中,Y7表示含有芳香環結構的二價基團;n1表示1至2的整數;Y71及Y72可為相同或不同,且分別地表示氫 或烷基,及 Wherein Y 7 represents a divalent group having an aromatic ring structure; n 1 represents an integer of 1 to 2; and Y 71 and Y 72 may be the same or different and each represents hydrogen or an alkyl group, and

Y8表示含有芳香環結構的二價基團;Y81及Y82可為相同或不同,且分別地表示氫或烷基。 Y 8 represents a divalent group containing an aromatic ring structure; Y 81 and Y 82 may be the same or different and each represents hydrogen or an alkyl group.

前述之四羧酸二酐化合物可以單獨使用一種或者混合複數種使用。 The above tetracarboxylic dianhydride compound may be used singly or in combination of plural kinds.

該脂肪族四羧酸二酐化合物包含但不限於乙烷四羧酸二酐、丁烷四羧酸二酐等。 The aliphatic tetracarboxylic dianhydride compound includes, but is not limited to, ethane tetracarboxylic dianhydride, butane tetracarboxylic dianhydride, and the like.

該脂環族四羧酸二酐化合物包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3',4,4'-二環己基四羧酸二酐、順-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐等。 The alicyclic tetracarboxylic dianhydride compound includes, but is not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutane Tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane IV Carboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutylcycloheptyl- 1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, bicyclo[2.2.2]-oct-7-ene- 2,3,5,6-tetracarboxylic dianhydride, and the like.

該芳香族四羧酸二酐化合物包含但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3',4,4'-二苯甲酮四羧酸二酐、3,3',4,4'-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3'-4,4'-二苯基乙烷四羧酸二酐、3,3',4,4'-二甲基二苯基矽烷四羧酸 二酐、3,3',4,4'-四苯基矽烷四羧酸二酐]、1,2,3,4-呋喃四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯硫醚二酐、4,4'-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯丙烷二酐、3,3',4,4'-全氟異亞丙基二苯二酸二酐、3,3',4,4'-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4'-二苯基醚二酐、雙(三苯基苯二酸)-4,4'-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮{(1,3,3a,4,5,9b-Hexahydro-5-(tetrahydro-2,5-dioxofuran-3-yl)naphtho[1,2-c]furan-1,3-dione)}、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫 -5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮,及5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等。 The aromatic tetracarboxylic dianhydride compound includes, but is not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3 ',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-biphenylfluorene tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride , 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3'-4,4'-diphenylethane tetracarboxylic dianhydride, 3,3',4,4'-dimethyl Diphenyldecane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylnonane tetracarboxylic dianhydride], 1,2,3,4-furan tetracarboxylic dianhydride, 4,4' - bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl phthalic anhydride, 4,4'-bis ( 3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene diphthalic dianhydride, 3,3',4,4'-di Phenyltetracarboxylic dianhydride, bis(phthalic acid)benzenephosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenyl) Phthalic acid) dianhydride, bis(triphenylbenzenedioic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride , ethylene glycol-bis (dehydrated trimellitate), propylene glycol-bis (dehydrated trimellitate), 1,4-butane - bis (hydrogen trimellitate), 1,6-hexanediol-bis (anhydrotrimellitic acid ester), 1,8-octanediol-bis(anhydrotrimellitic acid ester), 2,2 - bis(4-hydroxyphenyl)propane-bis(hydroper trimellitate), 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3 a ,4,5,9 b - Hexahydro-5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione {(1,3,3 a) ,4,5,9 b -Hexahydro-5-(tetrahydro-2,5-dioxofuran-3-yl)naphtho[1,2-c]furan-1,3-dione)}, 1,3,3 a , 4,5,9 b -hexahydro-5-methyl-5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho[1,2-c]-furan-1, 3-diketone, 1,3,3 a , 4,5,9 b -hexahydro-5-ethyl-5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho [1,2-c]-furan-1,3-dione, 1,3,3 a ,4,5,9 b -hexahydro-7-methyl-5-(tetrahydro-2,5-di Oxyloxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3 a ,4,5,9 b -hexahydro-7-ethyl -5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3 a , 4, 5,9 b -hexahydro-8-methyl-5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho[1,2-c]-furan-1,3- Diketone, 1,3,3 a , 4,5,9 b -hexahydro-8-ethyl-5-(tetrahydro-2,5-two side Oxy-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3 a , 4,5,9 b -hexahydro-5,8-di Methyl-5-(tetrahydro-2,5-di-oxy-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, and 5-(2,5 - Bis-oxytetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride.

較佳地,式(A-5)所示之四羧酸二酐化合物是選自於 Preferably, the tetracarboxylic dianhydride compound represented by formula (A-5) is selected from

較佳地,式(A-6)所示之四羧酸二酐化合物是 Preferably, the tetracarboxylic dianhydride compound represented by formula (A-6) is

該四羧酸二酐化合物的較佳具體例包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、1,2,4,5-環己烷四羧酸二酐、3,4-二羧基-1,2,3,4-四氫-萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3',4,4'-二苯甲酮四羧酸二酐、3,3',4,4'-聯苯碸四羧酸二酐,或前述的一組合。 Preferred specific examples of the tetracarboxylic dianhydride compound include, but are not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydro- Naphthalene-1-succinic dianhydride, benzene tetracarboxylic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-biphenyl fluorene Tetracarboxylic dianhydride, or a combination of the foregoing.

二胺組份Diamine component

該二胺組份包括一第一二胺化合物、一第二二胺化合,及不同於該第一及第二二胺化合物的其他二胺化合物。 The diamine component comprises a first diamine compound, a second diamine compound, and other diamine compounds different from the first and second diamine compounds.

第一二胺化合物First diamine compound

該第一二胺化合物是由式(I)所示: The first diamine compound is represented by the formula (I):

其中 R12及R14是獨立地選自於-O-、-S-、 R13表示一C2至C10的亞烷基,R11是選自於單鍵、亞甲基、伸乙基,及X表示一C17至C40具有膽固醇骨架的一價有機基團。 Wherein R 12 and R 14 are independently selected from -O-, -S-, , R 13 represents a C 2 to C 10 alkylene group, R 11 is a monovalent organic group selected from a single bond, a methylene group, an extended ethyl group, and X represents a C 17 to C 40 having a cholesterol skeleton.

該膽固醇骨架係指環戊烷-全氫菲(cyclopentano-perhydro phenanthrene)骨架,其中骨架中之一或多個碳-碳鍵可為雙鍵。 The cholesterol skeleton refers to a cyclopentano-perhydrophenanthrene skeleton in which one or more carbon-carbon bonds in the skeleton may be double bonds.

該膽固醇骨架包含但不限於下列式(X-1)至(X-4): 其中,X1可各自為下式之結構: +及*是獨立地表示一個結合鍵。 The cholesterol skeleton includes, but is not limited to, the following formulas (X-1) to (X-4): Wherein, X 1 can each be a structure of the following formula: + and * are independent representations of a binding key.

X的具體例包含但不限於下列式(X-1-1)至式(X-4-1), 其中,*是表示一個結合鍵。 Specific examples of X include, but are not limited to, the following formula (X-1-1) to formula (X-4-1), Where * is a binding key.

該第一二胺化合物包含但不限於下列式(I-1)至式(I-29), The first diamine compound includes, but is not limited to, the following formula (I-1) to formula (I-29),

第二二胺化合物Second diamine compound

由式(II)表示的該第二二胺化合物: 其中 R15是選自於-O-、 ,及,及R16表示一如式(II-1)所示的有機基團: The second diamine compound represented by the formula (II): Wherein R 15 is selected from -O-, , , , ,and And R 16 represents an organic group as shown in formula (II-1):

其中R17是各自獨立地選自於氫、氟及甲基;R18、R19或R20 各自獨立地選自於單鍵、-O-、,及C1至C3的伸烷基; R21是各自獨立地選自於, 其中R23及R24各自獨立地選自於氫、氟或甲基,R22是選自於氫、氟、C1至C12的烷基、C1至C12的氟烷基、C1至C12的烷氧基、-OCH2F、-OCHF2及-OCF3;k表示由1至2的正數,l、m及n是各自獨立地表示0至4的整數,o、p及q是各自獨立地表示0至3的整數,且條件是o+p+q≧3,及r及s是各自獨立地表示1或2。 Wherein R 17 is each independently selected from the group consisting of hydrogen, fluorine, and methyl; and R 18 , R 19 or R 20 are each independently selected from the group consisting of a single bond, -O-, , , , , And C 1 to C 3 alkylene; R 21 are each independently selected from and Wherein R 23 and R 24 are each independently selected from hydrogen, fluoro or methyl, and R 22 is selected from hydrogen, fluorine, C 1 to C 12 alkyl, C 1 to C 12 fluoroalkyl, C 1 to C 12 alkoxy group, -OCH 2 F, -OCHF 2 and -OCF 3 ; k represents a positive number from 1 to 2, and l, m and n are integers each independently representing 0 to 4, o, p And q are integers each independently representing 0 to 3, and the condition is o + p + q ≧ 3, and r and s each independently represent 1 or 2.

如式(II)所示的二胺化合物之具體例,可例如但不限於如式(II-2)至式(II-9)所示的二胺化合物: 其中,R25較佳地是選自於氫、C1至C12的烷基,及C1至C12的烷氧基。 Specific examples of the diamine compound represented by the formula (II) may be, for example but not limited to, a diamine compound represented by the formula (II-2) to the formula (II-9): Wherein R 25 is preferably an alkyl group selected from hydrogen, C 1 to C 12 , and a C 1 to C 12 alkoxy group.

較佳地,由式(II)表示的二胺化合物是選自於如下式(II-10)至(II-14)所示的二胺化合物: Preferably, the diamine compound represented by the formula (II) is a diamine compound selected from the following formulas (II-10) to (II-14):

前述之二胺化合物可以單獨使用一種或者混合複數種使用。 The above-mentioned diamine compounds may be used singly or in combination of plural kinds.

於本發明之液晶配向劑中,當用於形成聚合物組成物的該二胺組份未含有由式(I)所示的第一二胺化合物或式(II)所示的第二二胺化合物時,則包含該液晶配向劑所形成的液晶配向膜的液晶顯示元件具有照射紫外線後離子密度過高之問題。 In the liquid crystal alignment agent of the present invention, when the diamine component for forming a polymer composition does not contain the first diamine compound represented by the formula (I) or the second diamine represented by the formula (II) In the case of a compound, the liquid crystal display element including the liquid crystal alignment film formed by the liquid crystal alignment agent has a problem that the ion density is excessively high after irradiation with ultraviolet rays.

其他二胺化合物Other diamine compounds

不同於如式(I)及式(II)所示的第一及第二二胺化合物的其他二胺化合物的具體例可例如但不限於,1,2-二胺基乙烷[1,2-diaminoethane]、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4’-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺 基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基-3,3’-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺[isophoronediamine]、四氫二環戊二烯二胺[tetrahydrodicyclopentadienylene diamine]、三環(6.2.1.02,7)-十一碳烯二甲基二胺[tricyclic[6.2.1.02,7]-undecylenedimethylene diamine]、4,4’-亞甲基雙(環己基胺)、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基碸、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl)anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4’-亞甲基-雙(2-氯苯胺、4,4’-(對-伸苯基異亞丙基)雙苯胺、4,4’-(間-伸苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’- 雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane},以及如式(VI-1)至(VI-25)所示的二胺化合物: Specific examples of other diamine compounds different from the first and second diamine compounds represented by the formula (I) and the formula (II) may be, for example but not limited to, 1,2-diaminoethane [1, 2 -diaminoethane], 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diamino Heptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 4,4'-diaminoheptane, 1,3-diamine Base-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-dimethylheptane, 1,7 -diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2,11-di Aminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, 4,4'-diaminodicyclohexylmethane, 4,4 '-Diamino-3,3'-dimethyldicyclohexylamine, 1,3-diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine , tetrahydrodicyclopentadienylene diamine, tricyclic (6.2.1.0 2,7 )-undecene dimethyldiamine [tricyclic[6.2.1.0 2 ,7 ]-undecylened Imethylene diamine], 4,4'-methylenebis(cyclohexylamine), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4' -diaminodiphenylanthracene, 4,4'-diaminobenzimidanilide, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1, 5-Diaminonaphthalene, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroquinone, 6-amino-1-(4'-aminobenzene -1,3,3-trimethylhydroquinone, hexahydro-4,7-methyl bridge hydroquinone dimethylene diamine, 3,3'-diaminobenzophenone, 3, 4'-Diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2- Bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-amino) Phenoxy)phenyl]anthracene, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-amine Benzophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 9,10-bis(4-aminophenyl)anthracene [9,10-bis(4-aminophenyl) Anthracene], 2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis(2-chloroaniline, 4,4'-( p-Phenyl isopropylidene) diphenylamine, 4 , 4'-(m-phenylene isopropylidene) bisaniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenyl {5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}, 1,1-bis[4-(4-aminobenzene) Oxy)phenyl]-4-(4-ethylphenyl)cyclohexane {1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane}, and Diamine compounds shown in (VI-1) to (VI-25):

其中, R26表示-O-、 R27表示選自於下述的一價基團:含甾基團(steroid-containing group)、三氟甲基、氟基、C2-C30烷基,及衍生自吡啶[pyridine]、嘧啶[pyrimidine]、三嗪[triazine]、哌啶[piperidine]及哌嗪[piperazine]等含氮原子環狀結構的一價基團,及前述之一組合, Where R 26 represents -O-, , , , R 27 represents a monovalent group selected from the group consisting of a steroid-containing group, a trifluoromethyl group, a fluorine group, a C 2 -C 30 alkyl group, and a derivative derived from pyridine [pyridine] or pyrimidine. a monovalent group containing a cyclic structure of a nitrogen atom such as [pyrimidine], triazine, piperidine, and piperazine, and a combination thereof

其中,R28表示-O-、 R29及R30是各自獨立地表示選自於下列的二價基團: 伸脂肪族環、伸芳香族環,及伸雜環基團;及R31表示C3-C18烷基、C3-C18烷氧基、C1-C5氟烷基、C1-C5氟烷氧基、氰基,或鹵素原子; Where R 28 represents -O-, , , , R 29 and R 30 each independently represent a divalent group selected from the group consisting of an aliphatic ring, an extended aromatic ring, and a heterocyclic group; and R 31 represents a C 3 -C 18 alkyl group, C. a 3- C 18 alkoxy group, a C 1 -C 5 fluoroalkyl group, a C 1 -C 5 fluoroalkoxy group, a cyano group, or a halogen atom;

其中,Y3表示氫、C1-C5醯基、C1-C5烷基、C1-C5烷氧基或鹵素,且每個重複單元中的Y3可為相同或不同;及n2為1至3的整數; Wherein Y 3 represents hydrogen, C 1 -C 5 fluorenyl, C 1 -C 5 alkyl, C 1 -C 5 alkoxy or halogen, and Y 3 in each repeating unit may be the same or different; n 2 is an integer from 1 to 3;

其中,t為2至12的整數; Where t is an integer from 2 to 12;

其中,u為1至5的整數; Where u is an integer from 1 to 5;

其中,Y4及Y42可為相同或不同,且各自獨立地表示一二價有機基團;且Y41表示一衍生自吡啶、嘧啶、三嗪、哌啶,及哌嗪等含氮原子環狀結構的二價基團; Wherein, Y 4 and Y 42 may be the same or different, and each independently represent a twelve monovalent organic group; and Y 41 represents a derived from pyridine, pyrimidine, triazine, piperidine, and piperazine ring nitrogen atom a divalent group of a structure;

其中,Y5、Y51、Y52及Y53分別為相同或不同,且各自獨立地表示C1-C12烴基,p1代表由1至3之整數,且q1代表由1至20之整數; Wherein Y 5 , Y 51 , Y 52 and Y 53 are respectively the same or different and each independently represents a C 1 -C 12 hydrocarbon group, p 1 represents an integer from 1 to 3, and q 1 represents from 1 to 20 Integer

其中,Y6表示-O-或伸環己烷基,Y61表示-CH2-,Y62表示伸苯基或伸環己烷基,Y63代表氫或庚基; Wherein Y 6 represents -O- or a cyclohexane group, Y 61 represents -CH 2 -, Y 62 represents a phenyl or cyclohexane group, and Y 63 represents hydrogen or heptyl;

前述其他二胺化合物的具體例可以單獨使用一種或混合複數種使用。 Specific examples of the other diamine compound described above may be used singly or in combination of plural kinds.

較佳地,由式(VI-1)表示的二胺化合物的具體例包含2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)、 Preferably, a specific example of the diamine compound represented by the formula (VI-1) comprises 2,4-diaminophenyl ethyl formate, 3,5-diaminobenzene. 3,5-diaminophenyl ethyl formate, 2,4-diaminophenyl propyl formate, 3,5-diaminophenyl propyl formate (3 ,5-diaminophenyl propyl formate), 1-dodecoxy-2,4-diaminobenzene, 1-hexadecyloxy-2,4-diamine 1-hexadecoxy-2,4-diaminobenzene, 1-octadecoxy-2,4-diaminobenzene,

由式(VI-2)表示的二胺化合物的較佳具體例包含 A preferred specific example of the diamine compound represented by the formula (VI-2) contains

(其中v1表示一個由3至12的整數)、 (where v 1 represents an integer from 3 to 12),

(其中v2表示一個由3至12的整數)、 (where v 2 represents an integer from 3 to 12),

(其中v3表示一個由3至12的整數),及 (where v 3 represents an integer from 3 to 12), and

(其中v4表示一個由3至12的整數)。 (where v 4 represents an integer from 3 to 12).

較佳地,由式(VI-3)表示的二胺化合物的具體例包含:(1)當n為1:對-二胺苯、間-二胺苯、鄰-二胺苯、2,5-二胺甲苯等;(2)當n為2:4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基聯苯、3,3’-二氯-4,4’-二胺基聯苯、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯,及4,4’-二胺基-2,2’-雙(三氟甲基)聯苯等;(3)當n為3:1,4-雙(4’-胺基苯基)苯等。更佳地,由式(VI-3)表示的二胺化合物是選自於對-二胺苯、2,5-二胺甲苯、4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯,1,4-雙(4’-胺基苯基)苯,或前述之一組合。 Preferably, specific examples of the diamine compound represented by the formula (VI-3) include: (1) when n is 1: p-diamine benzene, m-diamine benzene, o-diamine benzene, 2, 5 -diamine toluene, etc.; (2) when n is 2:4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'- Dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-di Aminobiphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2, 2'-Dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, and 4,4'-diamino-2,2'-bis(trifluoromethyl) linkage Benzene, etc.; (3) when n is 3: 1,4-bis(4'-aminophenyl)benzene or the like. More preferably, the diamine compound represented by the formula (VI-3) is selected from the group consisting of p-diamine benzene, 2,5-diamine toluene, 4,4'-diaminobiphenyl, 3,3'- Dimethoxy-4,4'-diaminobiphenyl, 1,4-bis(4'-aminophenyl)benzene, or a combination of the foregoing.

較佳地,由式(VI-5)表示的二胺化合物的具體例為4,4’-二胺基二苯基硫醚。 Preferably, a specific example of the diamine compound represented by the formula (VI-5) is 4,4'-diaminodiphenyl sulfide.

較佳地,由式(VI-8)表示的二胺化合物的具體例是選自於 前述之一組合。 Preferably, a specific example of the diamine compound represented by the formula (VI-8) is selected from One of the aforementioned combinations.

較佳地,如式(VI-17)至(VI-20)所示的二胺化合物的B39是表示C1至C10烷基或C1至C10烷氧基;如式(VI-21)至(VI-25)所示的二胺化合物的B40是表示C1至C10烷基或C1至C10烷氧基。 Preferably, B 39 of the diamine compound represented by the formulae (VI-17) to (VI-20) represents a C 1 to C 10 alkyl group or a C 1 to C 10 alkoxy group; as in the formula (VI- B 40 of the diamine compound shown in 21) to (VI-25) represents a C 1 to C 10 alkyl group or a C 1 to C 10 alkoxy group.

適用於本發明的其他二胺化合物的較佳具體例包含但不限於4,4’-二胺基二環己基甲烷、4,4’-二胺基-3,3’-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環(6.2.1.02,7)-十一碳烯二甲基二胺、4,4’-亞甲基雙(環己基胺)、1,2-二胺基乙烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、式(VI-1-1)、式(VI-1-2)、式(VI-2-1)、式(VI-2-11)、對-二胺苯、間-二胺苯、鄰-二胺苯,或式(VI-8-1)所表示的化合物。 Preferred specific examples of other diamine compounds suitable for use in the present invention include, but are not limited to, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethylbicyclo Hexylamine, 1,3-diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadiene diamine, tricyclic (6.2.1 .0 2,7 ) -undecene dimethyldiamine, 4,4'-methylenebis(cyclohexylamine), 1,2-diaminoethane, 4,4'-diamine Diphenylmethane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminophenylcarboxylate, (VI-1-1), formula (VI-1-2), formula (VI-2-1), formula (VI-2-11), p-diamine benzene, m-diamine benzene, o-di Amine benzene, or a compound represented by the formula (VI-8-1).

較佳地,基於該二胺組份為100莫耳,該式(I)所示的第一二胺化合物的使用量為5至25莫耳,又較佳地為8至22莫耳,更佳地為10至20莫耳。 Preferably, the first diamine compound represented by the formula (I) is used in an amount of 5 to 25 moles, more preferably 8 to 22 moles, based on the diamine component being 100 moles. The best is 10 to 20 moles.

較佳地,基於該二胺組份為100莫耳,該式(II)所示的第二二胺化合物的使用量為5至25莫耳,又較佳地 為8至22莫耳,更佳地為10至20莫耳。 Preferably, the second diamine compound represented by the formula (II) is used in an amount of 5 to 25 moles, preferably more preferably 100 moles based on the diamine component. It is 8 to 22 moles, more preferably 10 to 20 moles.

較佳地,基於該二胺組份為100莫耳,該其他二胺化合物的使用量為50至90莫耳,又較佳地為56至84莫耳,更佳地為60至80莫耳。 Preferably, the other diamine compound is used in an amount of from 50 to 90 moles, more preferably from 56 to 84 moles, still more preferably from 60 to 80 moles, based on the diamine component being 100 moles. .

該聚合物組成物包含一聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物,及前述的組合。 The polymer composition comprises a poly-proline polymer, a polyimine polymer, a polyamidene block copolymer, and combinations of the foregoing.

聚醯胺酸聚合物Polylysine polymer

一聚醯胺酸聚合物是由將四羧酸二酐組份及二胺組份進行聚縮合反應所製得。該聚縮合反應是在0℃至100℃的溫度下於溶劑中進行聚縮合反應1小時至24小時以形成一反應溶液。接著再將上述的反應溶液以蒸發器進行減壓蒸餾方式,即可得到該聚醯胺酸聚合物。或者,將上述的反應溶液倒入大量的貧溶劑中,得到一析出物,接著於減壓下乾燥,即可得到該聚醯胺酸聚合物。 A poly-proline polymer is prepared by subjecting a tetracarboxylic dianhydride component and a diamine component to a polycondensation reaction. The polycondensation reaction is carried out by performing a polycondensation reaction in a solvent at a temperature of from 0 ° C to 100 ° C for from 1 hour to 24 hours to form a reaction solution. Then, the above reaction solution is subjected to distillation under reduced pressure in an evaporator to obtain the polyaminic acid polymer. Alternatively, the above reaction solution is poured into a large amount of a poor solvent to obtain a precipitate, which is then dried under reduced pressure to obtain the polyamic acid polymer.

較佳地,基於該二胺組份的總莫耳數為100莫耳,該四羧酸二酐組份的使用量範圍為20莫耳至200莫耳;更佳地,該四羧酸二酐組份的使用量範圍為30莫耳至120莫耳。 Preferably, the tetracarboxylic dianhydride component is used in an amount ranging from 20 moles to 200 moles based on the total mole number of the diamine component of 100 moles; more preferably, the tetracarboxylic acid II The anhydride component is used in an amount ranging from 30 moles to 120 moles.

該用於聚縮合反應中的溶劑可與該液晶配向劑中的溶劑相同或不同。此外,該用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。該溶劑的具體例包含但不限於(1)非質子系極性溶劑:1-甲基-2-吡咯烷酮(1-methyl-2-pyrrolidone)、氮,氮-二甲基乙醯胺、氮,氮-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿 素、六甲基磷酸三胺等;(2)酚系溶劑:間-甲酚、二甲苯酚、酚、鹵化酚類等。 The solvent used in the polycondensation reaction may be the same as or different from the solvent in the liquid crystal alignment agent. Further, the solvent used in the polycondensation reaction is not particularly limited as long as it is a soluble reactant and a product. Specific examples of the solvent include, but are not limited to, (1) an aprotic polar solvent: 1-methyl-2-pyrrolidone, nitrogen, nitrogen-dimethylacetamide, nitrogen, nitrogen. - dimethylformamide, dimethyl hydrazine, γ-butyrolactone, tetramethyl urinary Or hexamethylphosphoric acid triamide; (2) phenolic solvent: m-cresol, xylenol, phenol, halogenated phenol, and the like.

較佳地,基於該四羧酸二酐組份及二胺組份的混合物的總量為100重量份,該用於聚縮合反應中之溶劑的使用量範圍為200重量份至2,000重量份;更佳地,該用於聚縮合反應中之溶劑的使用量範圍為300重量份至1,800重量份。 Preferably, the solvent used in the polycondensation reaction is used in an amount ranging from 200 parts by weight to 2,000 parts by weight based on 100 parts by weight of the total of the mixture of the tetracarboxylic dianhydride component and the diamine component; More preferably, the solvent used in the polycondensation reaction is used in an amount ranging from 300 parts by weight to 1,800 parts by weight.

特別地,於該聚縮合反應中,前述該溶劑可併用適量的貧溶劑,只要不讓該聚醯胺酸聚合物析出即可。該貧溶劑可單獨或混合使用,且該貧溶劑包含但不限於(1)醇類:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇、三乙二醇等;(2)酮類:丙酮、甲基乙基酮、甲基異丁基酮、環己酮等;(3)酯類:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯、乙二醇乙基醚醋酸酯等;(4)醚類:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚、二乙二醇二甲基醚等;(5)鹵化烴類:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、鄰-二氯苯等;(6)烴類:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯、二甲苯等;或(7)前述之一組合。該貧溶劑的具體例可以單獨或合併使用。 In particular, in the polycondensation reaction, the solvent may be used in combination with an appropriate amount of a poor solvent as long as the polyamic acid polymer is not precipitated. The poor solvent may be used singly or in combination, and the poor solvent includes, but is not limited to, (1) an alcohol: methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, three Ethylene glycol, etc.; (2) ketones: acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.; (3) esters: methyl acetate, ethyl acetate, butyl acetate, oxalic acid Diethyl ester, diethyl malonate, ethylene glycol ethyl ether acetate, etc.; (4) ethers: diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol positive Ethyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, etc.; (5) halogenated hydrocarbons: dichloromethane, 1, 2 - Dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, etc.; (6) Hydrocarbons: tetrahydrofuran, hexane, heptane, octane, benzene, toluene , xylene, etc.; or (7) a combination of the foregoing. Specific examples of the poor solvent may be used singly or in combination.

較佳的,基於該二胺組份為100重量份,該貧溶劑的使用量範圍為0重量份至60重量份;更佳地,該貧溶劑的使用量範圍為0重量份至50重量份。 Preferably, the poor solvent is used in an amount ranging from 0 parts by weight to 60 parts by weight based on 100 parts by weight of the diamine component; more preferably, the poor solvent is used in an amount ranging from 0 parts by weight to 50 parts by weight. .

聚醯亞胺聚合物Polyimine polymer

該聚醯亞胺聚合物的製備方法包含將一包括四羧酸二酐組份及二胺組份的混合物溶解在溶劑中,進行聚合反應形成聚醯胺酸聚合物,並在脫水劑及觸媒的存在下,進一步加熱並進行脫水閉環反應,使得該聚醯胺酸聚合物中的醯胺酸官能基經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化),而得到聚醯亞胺聚合物。 The method for preparing the polyimine polymer comprises dissolving a mixture comprising a tetracarboxylic dianhydride component and a diamine component in a solvent, performing a polymerization reaction to form a poly-proline polymer, and the dehydrating agent and the contact In the presence of a medium, further heating and performing a dehydration ring-closure reaction, such that the proline functional group in the polyaminic acid polymer is converted into a quinone imine functional group (ie, ruthenium iodide) via a dehydration ring closure reaction to obtain a poly Yttrium imine polymer.

製備該聚醯亞胺聚合物中所使用的四羧酸二酐組份及二胺組份與上述製備該聚醯胺酸聚合物中所使用之該四羧酸二酐組份及該二胺組份相同。 a tetracarboxylic dianhydride component and a diamine component used in the preparation of the polyamidene polymer, and the tetracarboxylic dianhydride component and the diamine used in the preparation of the polyamic acid polymer described above The components are the same.

該用於脫水閉環反應中之溶劑可與該液晶配向劑中的溶劑相同,故不再贅述。較佳的,基於聚醯胺酸聚合物為100重量份,該用於脫水閉環反應中的溶劑的使用量範圍為200重量份至2,000重量份;更佳地,該用於脫水閉環反應中的溶劑的使用量範圍為300重量份至1,800重量份。 The solvent used in the dehydration ring closure reaction may be the same as the solvent in the liquid crystal alignment agent, and therefore will not be described again. Preferably, the solvent used in the dehydration ring closure reaction is used in an amount ranging from 200 parts by weight to 2,000 parts by weight based on 100 parts by weight of the polyamidamide polymer; more preferably, it is used in a dehydration ring closure reaction. The solvent is used in an amount ranging from 300 parts by weight to 1,800 parts by weight.

較佳地,該脫水閉環反應的操作溫度範圍為40℃至200℃,且更佳地為40℃至150℃。當該脫水閉環反應的操作溫度低於40℃時,將致使反應不完全,導致該聚醯胺酸聚合物的醯亞胺化程度變低。若該脫水閉環反應的操作溫度高於200℃時,所得的聚醯亞胺聚合物的重量平均分子量偏低。 Preferably, the dehydration ring closure reaction has an operating temperature in the range of from 40 ° C to 200 ° C, and more preferably from 40 ° C to 150 ° C. When the operating temperature of the dehydration ring-closure reaction is lower than 40 ° C, the reaction will be incomplete, resulting in a lower degree of oxime imidization of the poly-proline polymer. If the operating temperature of the dehydration ring-closure reaction is higher than 200 ° C, the weight average molecular weight of the obtained polyimine polymer is low.

本發明用於該液晶配向劑的該聚合物組成物的醯亞胺化率範圍較佳地為30至90%,又較佳地為40至85% ,更佳地為50至80%。當使用醯亞胺化率是在如上述所定義的範圍的聚合物組成物,具有由該液晶配向劑所形成之液晶配向膜的液晶顯示元件,可進一步降低照射紫外線後的離子密度。 The polymer composition of the present invention for the liquid crystal alignment agent preferably has a ruthenium iodide ratio of from 30 to 90%, more preferably from 40 to 85%. More preferably 50 to 80%. When a polymer composition having a ruthenium iodide ratio as defined above and a liquid crystal alignment film formed of the liquid crystal alignment agent is used, the ion density after ultraviolet irradiation can be further reduced.

用於脫水閉環反應中的脫水劑是包含但不限於酸酐類化合物,例如醋酸酐、丙酸酐、三氟醋酸酐等。對於每一莫耳該聚醯胺酸聚合物,該脫水劑的使用量範圍為0.01莫耳至20莫耳。該用於脫水閉環反應中的觸媒包含吡啶類化合物,例如吡啶、三甲基吡啶、二甲基吡啶等;三級胺類化合物,例如三乙基胺等。對於每一莫耳該脫水劑,該觸媒的使用量範圍為0.5莫耳至10莫耳。 The dehydrating agent used in the dehydration ring closure reaction is, but not limited to, an acid anhydride compound such as acetic anhydride, propionic anhydride, trifluoroacetic anhydride or the like. The dehydrating agent is used in an amount ranging from 0.01 moles to 20 moles per mole of the polyamine polymer. The catalyst used in the dehydration ring closure reaction comprises a pyridine compound such as pyridine, trimethylpyridine, lutidine or the like; a tertiary amine compound such as triethylamine. For each mole of the dehydrating agent, the catalyst is used in an amount ranging from 0.5 moles to 10 moles.

聚醯亞胺系嵌段共聚合物Polyimide block copolymer

該聚醯亞胺系嵌段共聚合物包含但不限於聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物,或前述之一組合。 The polyamidiminated block copolymer includes, but is not limited to, a polyphthalic acid block copolymer, a polyamidiene block copolymer, a polyphthalic acid-polyimine block copolymer. Or a combination of the foregoing.

較佳地,該聚醯亞胺系嵌段共聚合物的製備方法包含之步驟為:將一起始物溶於溶劑中,並進行聚縮合反應而得,其中,該起始物包括至少一如上所述之聚醯胺酸聚合物及/或至少一如上所述之聚醯亞胺聚合物,且進一步地還可包括四羧酸二酐組份及二胺組份。 Preferably, the method for preparing the polyamidiminated block copolymer comprises the steps of: dissolving a starting material in a solvent and performing a polycondensation reaction, wherein the starting material comprises at least one of the above The polyamic acid polymer and/or at least one polyimine polymer as described above, and further may further comprise a tetracarboxylic dianhydride component and a diamine component.

該起始物中之四羧酸二酐組份及二胺組份是與上述製備聚醯胺酸聚合物中所使用的四羧酸二酐組份及二胺組份相同,且該用於聚縮合反應中的溶劑可與該液晶配向劑中的溶劑相同,故不再贅述。 The tetracarboxylic dianhydride component and the diamine component in the starting material are the same as the tetracarboxylic dianhydride component and the diamine component used in the preparation of the polyamic acid polymer described above, and the same is used for The solvent in the polycondensation reaction may be the same as the solvent in the liquid crystal alignment agent, and therefore will not be described again.

較佳的,基於該起始物為100重量份,該用於聚縮合反應中之溶劑的使用量範圍為200重量份至2,000重量份;更佳地,該用於聚縮合反應中之溶劑的使用量範圍為300重量份至1,800重量份。 Preferably, the solvent used in the polycondensation reaction is used in an amount ranging from 200 parts by weight to 2,000 parts by weight based on 100 parts by weight of the starting material; more preferably, the solvent used in the polycondensation reaction The amount used ranges from 300 parts by weight to 1,800 parts by weight.

較佳地,該聚縮合反應的操作溫度範圍為0℃至200℃;更佳地,該聚縮合反應的操作溫度範圍0℃至100℃。 Preferably, the polycondensation reaction is operated at a temperature ranging from 0 ° C to 200 ° C; more preferably, the polycondensation reaction is operated at a temperature ranging from 0 ° C to 100 ° C.

較佳地,該起始物包含但不限於(1)第一及第二聚醯胺酸聚合物的末端基及結構相異;(2)第一及第二聚醯亞胺聚合物的末端基及結構相異;(3)聚醯胺酸化合物及聚醯亞胺聚合物末端基及結構相異;(4)聚醯胺酸聚合物、四羧酸二酐組份及二胺組份,其中,該四羧酸二酐組份及二胺組份之中至少一種與形成聚醯胺酸聚合物所使用的四羧酸二酐組份及二胺組份構造相異;(5)聚醯亞胺聚合物、四羧酸二酐組份及二胺組份,其中,該四羧酸二酐組份及二胺組份至少一種與形成聚醯亞胺聚合物所使用的四羧酸二酐組份及二胺組份構造相異;(6)聚醯胺酸聚合物、聚醯亞胺聚合物、四羧酸二酐組份及二胺組份,其中,該四羧酸二酐組份及二胺組份至少一種與形成聚醯胺酸聚合物及聚醯亞胺聚合物所使用的四羧酸二酐組份及二胺組份構造相異;(7)結構相異之第一及第二聚醯胺酸聚合物、四羧酸二酐組份及二胺組份;(8)結構相異之第一及第二聚醯亞胺聚合物、四羧酸二酐組份及二胺組份;(9)末端基為酸酐基且結構相異的第一及第二聚醯胺酸聚合物,及二胺組份;(10) 末端基為胺基且結構相異的第一及第二聚醯胺酸聚合物,及四羧酸二酐類組份;(11)末端基為酸酐基且結構相異的第一及第二聚醯亞胺聚合物,及二胺類組份;(12)末端基為胺基且結構相異的第一及第二聚醯亞胺聚合物,及四羧酸二酐組份。 Preferably, the starting material comprises, but is not limited to, (1) the terminal groups and structures of the first and second poly-proline polymers are different; (2) the ends of the first and second polyimine polymers The base and structure are different; (3) the poly-proline and polyimine polymers have different terminal groups and structures; (4) poly-proline polymer, tetracarboxylic dianhydride component and diamine component Wherein at least one of the tetracarboxylic dianhydride component and the diamine component is different from the tetracarboxylic dianhydride component and the diamine component structure used to form the polyamic acid polymer; (5) a polyimine polymer, a tetracarboxylic dianhydride component and a diamine component, wherein at least one of the tetracarboxylic dianhydride component and the diamine component and the tetracarboxylic acid used for forming the polyimine polymer The acid dianhydride component and the diamine component are structurally different; (6) a poly-proline polymer, a polyimine polymer, a tetracarboxylic dianhydride component, and a diamine component, wherein the tetracarboxylic acid At least one of the dianhydride component and the diamine component is different from the tetracarboxylic dianhydride component and the diamine component structure used for forming the polyphthalic acid polymer and the polyamidene polymer; (7) structural phase First and second a proline polymer, a tetracarboxylic dianhydride component, and a diamine component; (8) a first and a second polyimine polymer having a structural difference, a tetracarboxylic dianhydride component, and a diamine component (9) first and second polyaminic acid polymers having terminal groups which are anhydride groups and structurally different, and diamine components; (10) First and second polyamic acid polymers having an amine group and a different structure, and a tetracarboxylic dianhydride component; (11) first and second having an acid anhydride group and different structures a polyimine polymer, and a diamine component; (12) a first and a second polyimine polymer having an amine group and a different structure, and a tetracarboxylic dianhydride component.

較佳地,在不影響本發明之功效範圍內,該聚醯胺酸聚合物、該聚醯亞胺聚合物,及該聚醯亞胺系嵌段共聚合物可以是先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善該液晶配向劑的塗佈性能。該末端修飾型聚合物的製造方式,可藉由在該聚醯胺酸聚合物進行聚縮合反應的同時,加入一單官能性化合物而製得。 Preferably, the polyaminic acid polymer, the polyamidiene polymer, and the polyamidene block copolymer may be molecular weight adjusted first, without affecting the efficacy of the present invention. End modified polymer. The coating property of the liquid crystal alignment agent can be improved by using a terminal-modified polymer. The method for producing the terminal modified polymer can be obtained by adding a monofunctional compound while carrying out a polycondensation reaction of the polyamic acid polymer.

該單官能性化合物的具體例包含但不限於(1)一元酸酐:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐、正十六烷基琥珀酸酐等;(2)單胺化合物:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺、正二十烷胺等;(3)單異氰酸酯化合物:異氰酸苯酯、異氰酸萘基酯等。 Specific examples of the monofunctional compound include, but are not limited to, (1) monobasic acid anhydride: maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecane Succinic anhydride, n-hexadecyl succinic anhydride, etc.; (2) monoamine compound: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, positive Indoleamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecaneamine, n-octadecylamine , n-icosylamine, etc.; (3) monoisocyanate compound: phenyl isocyanate, naphthyl isocyanate, and the like.

本發明聚合物組成物以凝膠滲透色層分析法(GPC)測量的重量平均分子量範圍為2,000至200,000,較佳地為3,000至100,000,更佳地為4,000至50,000。 The polymer composition of the present invention has a weight average molecular weight measured by gel permeation chromatography (GPC) ranging from 2,000 to 200,000, preferably from 3,000 to 100,000, more preferably from 4,000 to 50,000.

聚矽氧烷Polyoxane

該聚矽氧烷是由將一含有環氧基基團的聚矽氧烷化合物及一具有C4至C50之側鏈的羧酸化合物進行反應所製得。 The polyoxyalkylene is produced by reacting a polyoxyalkylene compound containing an epoxy group and a carboxylic acid compound having a side chain of C 4 to C 50 .

較佳的,該含有環氧基基團的聚矽氧烷化合物是由一矽烷化合物組份聚縮合而形成,該矽烷化合物組份包含一如式(III)所示的第一矽烷化合物:Si(R32)y(OR33)4-y (III) Preferably, the epoxy group-containing polyoxyalkylene compound is formed by polycondensation of a monodecane compound component comprising a first decane compound represented by formula (III): Si (R 32 ) y (OR 33 ) 4-y (III)

其中,至少一的R32是選自於式(B-1)、式(B-2)或式(B-3)的官能基,其餘的R32是獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R33是各自獨立地選自於氫原子、C1至C6的烷基、C1至C6的醯基,及C6至C15的芳基,及Y表示1至3的整數; Wherein at least one R 32 is a functional group selected from the group consisting of the formula (B-1), the formula (B-2) or the formula (B-3), and the remaining R 32 is independently selected from a hydrogen atom, C 1 An alkyl group of C 10 , a C 2 to C 10 alkenyl group, and a C 6 to C 15 aryl group, and R 33 are each independently selected from a hydrogen atom, a C 1 to C 6 alkyl group, and C 1 to C 6 acyl, and C 6 to C 15 aryl group, and Y represents and integer of 1 to 3;

其中A是選自於氧原子或單鍵,h是表示由1至3的整數,及i是表示由0至6的整數,且條件是當i為0時,A表示一單鍵, Wherein A is selected from an oxygen atom or a single bond, h is an integer represented by 1 to 3, and i is an integer represented by 0 to 6, and the condition is that when i is 0, A represents a single bond,

其中j是表示由0至6的整數, Where j is an integer representing from 0 to 6,

其中B1是表示C2至C6之伸烷基;R34表示氫原子或C1至C6之烷基。 Wherein B 1 is an alkylene group representing C 2 to C 6 ; R 34 represents a hydrogen atom or an alkyl group of C 1 to C 6 .

較佳的,除了如前所述的如式(III)所示的第一矽烷化合物,該矽烷化合物還包含一如式(IV)所示的該第二矽烷化合物:Si(R35)b(OR36)4-b (IV) Preferably, in addition to the first decane compound represented by the formula (III) as described above, the decane compound further comprises the second decane compound represented by the formula (IV): Si(R 35 ) b ( OR 36 ) 4-b (IV)

其中,R35是各自獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R36是各自獨立地選自於氫原子、C1至C6的烷基、C1至C6的醯基,或C6至C15的芳基,及b表示由0至3的整數。 Wherein R 35 is each independently selected from a hydrogen atom, a C 1 to C 10 alkyl group, a C 2 to C 10 alkenyl group, and a C 6 to C 15 aryl group, and R 36 is each independently selected from the group consisting of a hydrogen atom, a C 1 to C 6 alkyl group, a C 1 to C 6 fluorenyl group, or a C 6 to C 15 aryl group, and b represents an integer of 0 to 3.

較佳地,該羧酸化合物具有C6-C50之側鏈。 Preferably, the carboxylic acid compound has a C 6 -C 50 side chain.

當該液晶配向劑不含有該聚矽氧烷,含有由該液晶配向劑形成的液晶配向膜的液晶顯示元件在紫外線照射後會具有較差的電壓保持率。 When the liquid crystal alignment agent does not contain the polyoxyalkylene oxide, the liquid crystal display element containing the liquid crystal alignment film formed of the liquid crystal alignment agent has a poor voltage holding ratio after ultraviolet irradiation.

較佳地,基於聚合物組成物為100重量份,該聚矽氧烷的使用量為3至30重量份,又較佳地為4至25重量份,更佳地為5至20重量份。 Preferably, the polysiloxane is used in an amount of from 3 to 30 parts by weight, more preferably from 4 to 25 parts by weight, still more preferably from 5 to 20 parts by weight, based on 100 parts by weight of the polymer composition.

第一矽烷化合物First decane compound

該第一矽烷化合物是如式(III)所示:Si(R32)y(OR33)4-y (III) The first silicon compound is alkoxy as shown in the formula (III): Si (R 32 ) y (OR 33) 4-y (III)

其中,至少一的R32是選自於式(B-1)、式(B-2)或式(B-3)的官能基,其餘的R32是獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R33是各自獨立地選自於氫原子、C1至C6的烷基、C1 至C6的醯基,及C6至C15的芳基,及Y表示1至3的整數。 Wherein at least one R 32 is a functional group selected from the group consisting of the formula (B-1), the formula (B-2) or the formula (B-3), and the remaining R 32 is independently selected from a hydrogen atom, C 1 An alkyl group of C 10 , a C 2 to C 10 alkenyl group, and a C 6 to C 15 aryl group, and R 33 are each independently selected from a hydrogen atom, a C 1 to C 6 alkyl group, and C 1 to C 6 acyl, and C 6 to C 15 aryl group, and Y represents and integer of 1 to 3.

如式(III)所示的該第一矽烷化合物的具體例包含但不限於3-(氮,氮-二縮水甘油基)胺基丙基三甲氧基矽烷[3-(N,N-diglycidyl)aminopropyl trimethoxysilane]、3-(氮-烯丙基-氮-縮水甘油基)胺基丙基三甲氧基矽烷[3-(N-allyl-N-glycidyl)aminopropyl trimethoxysilane]、3-縮水甘油醚基丙基三甲氧基矽烷、3-縮水甘油醚基丙基三乙氧基矽烷、3-縮水甘油醚基丙基甲基二甲氧基矽烷、3-縮水甘油醚基丙基甲基二乙氧基矽烷、3-縮水甘油醚基丙基二甲基甲氧基矽烷、3-縮水甘油醚基丙基二甲基乙氧基矽烷、2-縮水甘油醚基乙基三甲氧基矽烷、2-縮水甘油醚基乙基三乙氧基矽烷、2-縮水甘油醚基乙基甲基二甲氧基矽烷、2-縮水甘油醚基乙基甲基二乙氧基矽烷、2-縮水甘油醚基乙基二甲基甲氧基矽烷、2-縮水甘油醚基乙基二甲基乙氧基矽烷、4-縮水甘油醚基丁基三甲氧基矽烷、4-縮水甘油醚基丁基三乙氧基矽烷、4-縮水甘油醚基丁基甲基二甲氧基矽烷、4-縮水甘油醚基丁基甲基二乙氧基矽烷、4-縮水甘油醚基丁基二甲基甲氧基矽烷、4-縮水甘油醚基丁基二甲基乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷[2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane]、2-(3,4-環氧環己基)乙基三乙氧基矽烷、3-(3,4-環氧環己基)丙基三甲氧基矽烷、3-(3,4-環氧環己基)丙基三乙氧基矽烷、[(3-乙基-3-環氧丙烷基)甲氧基]丙基三甲氧基矽烷、[(3-乙基-3- 環氧丙烷基)甲氧基]丙基三乙氧基矽烷、[(3-乙基-3-環氧丙烷基)甲氧基]丙基甲基二甲氧基矽烷,及[(3-乙基-3-環氧丙烷基)甲氧基]丙烷二甲基甲氧基矽烷等。該等化合物可單獨使用一種或混合複數種使用。 Specific examples of the first decane compound represented by the formula (III) include, but are not limited to, 3-(nitrogen, nitrogen-diglycidyl)aminopropyltrimethoxydecane [3-(N,N-diglycidyl). Aminopropyl trimethoxysilane], 3-(N-allyl-N-glycidyl)aminopropyl trimethoxysilane, 3-glycidyl ether Trimethoxy decane, 3-glycidyl ether propyl triethoxy decane, 3-glycidyl ether propyl methyl dimethoxy decane, 3-glycidyl ether propyl methyl diethoxy Decane, 3-glycidyl ether propyl dimethyl methoxy decane, 3-glycidyl ether propyl dimethyl ethoxy decane, 2-glycidyl ether ethyl trimethoxy decane, 2-shrink Glyceryl ether ethyl triethoxy decane, 2-glycidyl ether ethyl methyl dimethoxy decane, 2-glycidyl ether ethyl methyl diethoxy decane, 2-glycidyl ether Dimethyl methoxy decane, 2-glycidyl ether ethyl dimethyl ethoxy decane, 4-glycidyl ether butyl trimethoxy decane, 4-glycidyl ether butyl triethyl Oxydecane, 4-glycidyl ether butyl methyl dimethoxy decane, 4-glycidyl ether butyl methyl diethoxy decane, 4-glycidyl ether butyl dimethyl methoxy decane, 4- Glycidyl ether butyl dimethyl ethoxy decane, 2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane, 2-(3) , 4-epoxycyclohexyl)ethyltriethoxydecane, 3-(3,4-epoxycyclohexyl)propyltrimethoxydecane, 3-(3,4-epoxycyclohexyl)propyltri Ethoxydecane, [(3-ethyl-3-epoxypropenyl)methoxy]propyltrimethoxydecane, [(3-ethyl-3- Epoxypropenyl)methoxy]propyltriethoxydecane, [(3-ethyl-3-epoxypropenyl)methoxy]propylmethyldimethoxydecane, and [(3- Ethyl-3-epoxypropenyl)methoxy]propane dimethyl methoxydecane, and the like. These compounds may be used singly or in combination of plural kinds.

在上述如式(III)所示的該第一矽烷化合物,較佳的是3-縮水甘油醚基丙基三甲氧基矽烷、2-縮水甘油醚基乙基三甲氧基矽烷、4-縮水甘油醚基丁基三甲氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、2-(3,4-環氧環己基)乙基三乙氧基矽烷、[(3-乙基-3-環氧丙烷基)甲氧基]丙基三甲氧基矽烷、[(3-乙基-3-環氧丙烷基)甲氧基]丙基三乙氧基矽烷,及前述之一組合。 In the above first decane compound represented by the formula (III), preferred is 3-glycidyl ether propyl trimethoxy decane, 2-glycidyl ether ethyl trimethoxy decane, 4-glycidol. Ether butyl trimethoxy decane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxy decane, 2-(3,4-epoxycyclohexyl)ethyltriethoxy decane, [( 3-ethyl-3-epoxypropenyl)methoxy]propyltrimethoxydecane, [(3-ethyl-3-epoxypropenyl)methoxy]propyltriethoxydecane, and One of the aforementioned combinations.

基於該矽烷化合物組份為1莫耳,式(III)所示的該第一矽烷化合物的使用量為0.3至1.0莫耳,較佳地是0.35至0.95莫耳,更佳地是0.4至0.9莫耳。 The first decane compound represented by the formula (III) is used in an amount of from 0.3 to 1.0 mol, preferably from 0.35 to 0.95 mol, more preferably from 0.4 to 0.9, based on 1 mol of the decane compound component. Moor.

第二矽烷化合物Second decane compound

該第二矽烷化合物是如式(IV)所示:Si(R35)b(OR36)4-b (IV) The second decane compound is as shown in formula (IV): Si(R 35 ) b (OR 36 ) 4-b (IV)

其中,R35是各自獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R36是各自獨立地選自於氫原子、C1至C6的烷基、C1至C6的醯基,或C6至C15的芳基,及b表示由0至3的整數。 Wherein R 35 is each independently selected from a hydrogen atom, a C 1 to C 10 alkyl group, a C 2 to C 10 alkenyl group, and a C 6 to C 15 aryl group, and R 36 is each independently selected from the group consisting of a hydrogen atom, a C 1 to C 6 alkyl group, a C 1 to C 6 fluorenyl group, or a C 6 to C 15 aryl group, and b represents an integer of 0 to 3.

當b為0,該第二矽烷化合物表示四官能矽烷化合物。當b為1,該第二矽烷化合物表示三官能矽烷化合物。當b為2,該第二矽烷化合物表示雙官能矽烷化合物。當 b為3,該第二矽烷化合物表示單官能矽烷化合物。 When b is 0, the second decane compound represents a tetrafunctional decane compound. When b is 1, the second decane compound represents a trifunctional decane compound. When b is 2, the second decane compound represents a difunctional decane compound. when b is 3, and the second decane compound represents a monofunctional decane compound.

如式(IV)所示的該第二矽烷化合物的具體例包含但不限於(1)四官能矽烷化合物,例如四氯矽烷[tetrachlorosilane]、四甲氧基矽烷、四乙氧基矽烷、四正丙氧基矽烷、四異丙氧基矽烷、四正丁氧基矽烷、四二級丁氧基矽烷等;(2)三官能矽烷化合物,例如三氯矽烷、三甲氧基矽烷、三乙氧基矽烷、氟三氯矽烷、氟三甲氧基矽烷、氟三乙氧基矽烷;甲基三氯矽烷;甲基三甲氧基矽烷、甲基三乙氧基矽烷、2-(三氟甲基)乙基三氯矽烷、2-(三氟甲基)乙基三甲氧基矽烷、2-(三氟甲基)乙基三乙氧基矽烷、羥甲基三氯矽烷、羥甲基三甲氧基矽烷、羥乙基三甲氧基矽烷、巰甲基三氯矽烷、3-巰丙基三氯矽烷、巰甲基三甲氧基矽烷、巰甲基三乙氧基矽烷、3-巰丙基三甲氧基矽烷、3-巰丙基三乙氧基矽烷、苯基三氯矽烷、苯基三甲氧基矽烷、苯基三乙氧基矽烷;(3)雙官能矽烷化合物,例如甲基二氯矽烷[methyl dichlorosilane]、甲基二甲氧基矽烷、甲基二乙氧基矽烷、二甲基二氯矽烷、二甲基二甲氧基矽烷、二甲基二乙氧基矽烷、甲基[2-(全氟正辛基)乙基]二氯矽烷、甲基[2-(全氟正辛基)乙基]二甲氧基矽烷、3-巰丙基甲基二氯矽烷、3-巰丙基甲基二甲氧基矽烷、二苯基二氯矽烷、二苯基二甲氧基矽烷等;(4)單官能矽烷化合物,例如氯二甲基矽烷[chlorodimethylsilane]、甲氧基二甲基矽烷、氯三甲基矽烷、溴三甲基矽烷、碘三甲基矽烷、甲氧基三甲基矽烷、氯甲基二苯基矽烷、甲氧基甲基二苯基 矽烷等。 Specific examples of the second decane compound represented by the formula (IV) include, but are not limited to, (1) a tetrafunctional decane compound such as tetrachlorosilane, tetramethoxy decane, tetraethoxy decane, tetra-negative Propoxy decane, tetraisopropoxy decane, tetra-n-butoxy decane, tetra- or 2-butoxybutane, etc.; (2) trifunctional decane compounds such as trichlorodecane, trimethoxy decane, triethoxy Decane, fluorotrichlorodecane, fluorotrimethoxydecane, fluorotriethoxydecane; methyltrichlorodecane; methyltrimethoxydecane, methyltriethoxydecane, 2-(trifluoromethyl)B Trichlorodecane, 2-(trifluoromethyl)ethyltrimethoxydecane, 2-(trifluoromethyl)ethyltriethoxydecane, methyloltrichlorodecane, hydroxymethyltrimethoxydecane , hydroxyethyltrimethoxydecane, decylmethyltrichlorodecane, 3-mercaptopropyltrichlorodecane, decylmethyltrimethoxydecane, decylmethyltriethoxydecane, 3-mercaptopropyltrimethoxy Decane, 3-mercaptopropyltriethoxydecane, phenyltrichlorodecane, phenyltrimethoxydecane, phenyltriethoxydecane; (3) difunctional decane For example, methyl dichlorosilane, methyl dimethoxy decane, methyl diethoxy decane, dimethyl dichloro decane, dimethyl dimethoxy decane, dimethyl di Oxydecane, methyl [2-(perfluoro-n-octyl)ethyl]dichlorodecane, methyl [2-(perfluoro-n-octyl)ethyl]dimethoxydecane, 3-mercaptopropyl Dichlorodecane, 3-mercaptopropylmethyldimethoxydecane, diphenyldichlorodecane, diphenyldimethoxydecane, etc.; (4) monofunctional decane compounds, such as chlorodimethyl decane [ Chlorodimethylsilane], methoxydimethyl decane, chlorotrimethyl decane, bromotrimethyl decane, iodine trimethyl decane, methoxy trimethyl decane, chloromethyl diphenyl decane, methoxymethyl Diphenyl Decane and so on.

如式(IV)所示的該第二矽烷化合物的市售商品具體例例如:由信越化學製造的KC-89、KC-89S、X-21-3153、X-21-5841、X-21-5842、X-21-5843、X-21-5844、X-21-5845、X-21-5846、X-21-5847、X-21-5848、X-22-160AS、X-22-170B、X-22-170BX、X-22-170D、X-22-170DX、X-22-176B、X-22-176D、X-22-176DX、X-22-176F、X-40-2308、X-40-2651、X-40-2655A、X-40-2671、X-40-2672、X-40-9220、X-40-9225、X-40-9227、X-40-9246、X-40-9247、X-40-9250、X-40-9323、X-41-1053、X-41-1056、X-41-1805、X-41-1810、KF6001、KF6002、KF6003、KR212、KR-213、KR-217、KR220L、KR242A、KR271、KR282、KR300、KR311、KR401N、KR500、KR510、KR5206、KR5230、KR5235、KR9218,及KR9706;由昭和電工製造的Glass Resin;由Dow Corning Toray製造的SH804、SH805、SH806A、SH840、SR2400、SR2402、SR2405、SR2406、SR2410、SR2411、SR2416,及SR2420;由NUC製造的FZ3711及FZ3722;由JNC製造的DMS-S12、DMS-S15、DMS-S21、DMS-S27、DMS-S31、DMS-S32、DMS-S33、DMS-S35、DMS-S38、DMS-S42、DMS-S45、DMS-S51、DMS-227、PSD-0332、PDS-1615、PDS-9931,及XMS-5025;由三菱化學製造的矽酸甲酯MS51及矽酸甲酯MS56;由Colcoat製造的矽酸乙酯28、矽酸乙酯40及矽酸乙酯48;及由昭和電工製造的GR100、GR650、GR908及GR950。 Specific examples of commercially available products of the second decane compound represented by the formula (IV) are, for example, KC-89, KC-89S, X-21-3153, X-21-5841, X-21- manufactured by Shin-Etsu Chemical Co., Ltd. 5842, X-21-5843, X-21-5844, X-21-5845, X-21-5846, X-21-5847, X-21-5848, X-22-160AS, X-22-170B, X-22-170BX, X-22-170D, X-22-170DX, X-22-176B, X-22-176D, X-22-176DX, X-22-176F, X-40-2308, X- 40-2651, X-40-2655A, X-40-2671, X-40-2672, X-40-9220, X-40-9225, X-40-9227, X-40-9246, X-40- 9247, X-40-9250, X-40-9323, X-41-1053, X-41-1056, X-41-1805, X-41-1810, KF6001, KF6002, KF6003, KR212, KR-213, KR-217, KR220L, KR242A, KR271, KR282, KR300, KR311, KR401N, KR500, KR510, KR5206, KR5230, KR5235, KR9218, and KR9706; Glass Resin manufactured by Showa Denko; SH804, SH805 manufactured by Dow Corning Toray , SH806A, SH840, SR2400, SR2402, SR2405, SR2406, SR2410, SR2411, SR2416, and SR2420; FZ3711 and FZ3722 manufactured by NUC; DMS-S12, DMS-S15, DMS-S21, DMS-S27 manufactured by JNC, DMS-S31, DMS-S32, DMS-S33, D MS-S35, DMS-S38, DMS-S42, DMS-S45, DMS-S51, DMS-227, PSD-0332, PDS-1615, PDS-9931, and XMS-5025; methyl decanoate manufactured by Mitsubishi Chemical MS51 and methyl decanoate MS56; ethyl decanoate 28, ethyl citrate 40 and ethyl decanoate 48 manufactured by Colcoat; and GR100, GR650, GR908 and GR950 manufactured by Showa Denko.

在上述如式(IV)所示的該第二矽烷化合物中,較佳的是四甲氧基矽烷、四乙氧基矽烷、甲基三甲氧基矽烷、甲基三乙氧基矽烷、苯基三甲氧基矽烷、苯基三乙氧基矽烷、3-巰丙基甲基二氯矽烷、3-巰丙基甲基二甲氧基矽烷、巰甲基三甲氧基矽烷、巰甲基三乙氧基矽烷、二甲基二甲氧基矽烷、二甲基二乙氧基矽烷,或前述之一組合。 Among the above second decane compounds represented by the formula (IV), preferred are tetramethoxy decane, tetraethoxy decane, methyl trimethoxy decane, methyl triethoxy decane, and phenyl. Trimethoxydecane, phenyltriethoxydecane, 3-mercaptopropylmethyldichlorodecane, 3-mercaptopropylmethyldimethoxydecane, decylmethyltrimethoxydecane, decylmethyltriethyl Oxydecane, dimethyldimethoxydecane, dimethyldiethoxydecane, or a combination of the foregoing.

基於該矽烷化合物組份為1莫耳,式(IV)所示的該第二矽烷化合物的使用量為0至0.7莫耳,較佳地是0.05至0.65莫耳,更佳地是0.1至0.6莫耳。 The second decane compound represented by the formula (IV) is used in an amount of from 0 to 0.7 mol, preferably from 0.05 to 0.65 mol, more preferably from 0.1 to 0.6, based on 1 mol of the decane compound component. Moor.

製備含有環氧基基團的聚矽氧烷的方法Method for preparing polyoxyalkylene containing epoxy groups

製備該含有環氧基基團的聚矽氧烷的縮合反應可使用一般的方法。例如,在上述矽烷化合物或其混合物中添加有機溶劑、水或選擇性地進一步添加觸媒,接著利用油浴等進行50℃至150℃的加熱,較佳加熱時間為0.5小時至120小時。加熱中,可將混合液進行攪拌,也可以置於回流條件下。 A general method can be used for the condensation reaction of preparing the epoxy group-containing polyoxyalkylene. For example, an organic solvent, water or a catalyst is further added to the above decane compound or a mixture thereof, followed by heating at 50 ° C to 150 ° C by an oil bath or the like, preferably for 0.5 to 120 hours. While heating, the mixture may be stirred or placed under reflux.

上述有機溶劑並沒有特別限制,可與本發明液晶配向劑中所包含的溶劑為相同或不同。 The above organic solvent is not particularly limited and may be the same as or different from the solvent contained in the liquid crystal alignment agent of the present invention.

該有機溶劑是選自於烴類化合物、酮類化合物、酯類化合物、醚類化合物,及醇類化合物。 The organic solvent is selected from the group consisting of a hydrocarbon compound, a ketone compound, an ester compound, an ether compound, and an alcohol compound.

前述烴類化合物的具體例包括甲苯及二甲苯;前述酮類化合物的具體例包括甲基乙基酮、甲基異丁基酮、甲基正戊基酮、二乙基酮,及環己酮;前述酯類化合物的具體例包括乙酸乙酯、乙酸正丁酯、乙酸異戊酯、丙二 醇單甲醚乙酸酯、3-甲氧基丁基乙酸酯,及乳酸乙酯;前述醚類化合物的具體例包括乙二醇二甲醚、乙二醇二乙醚、四氫呋喃,及二惡烷;前述醇類化合物的具體例包括1-己醇、4-甲基-2-戊醇、乙二醇單甲醚乙二醇單乙醚、乙二醇單正丙基醚、乙二醇單正丁基醚、丙二醇單甲醚、丙二醇單乙醚,及丙二醇單正丙基醚。該有機溶劑可單獨使用,或合併兩種或兩種以上使用。 Specific examples of the hydrocarbon compound include toluene and xylene; and specific examples of the ketone compound include methyl ethyl ketone, methyl isobutyl ketone, methyl n-pentyl ketone, diethyl ketone, and cyclohexanone. Specific examples of the aforementioned ester compound include ethyl acetate, n-butyl acetate, isoamyl acetate, and propylene Alcohol monomethyl ether acetate, 3-methoxybutyl acetate, and ethyl lactate; specific examples of the ether compound include ethylene glycol dimethyl ether, ethylene glycol diethyl ether, tetrahydrofuran, and dioxins Specific examples of the aforementioned alcohol compound include 1-hexanol, 4-methyl-2-pentanol, ethylene glycol monomethyl ether glycol monoethyl ether, ethylene glycol mono-n-propyl ether, ethylene glycol single n-Butyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, and propylene glycol mono-n-propyl ether. The organic solvent may be used singly or in combination of two or more.

較佳地,基於全部的該矽烷化合物為100重量份,該有機溶劑的用量是10至10,000重量份,更佳地為50至1,000重量份。 Preferably, the organic solvent is used in an amount of 10 to 10,000 parts by weight, more preferably 50 to 1,000 parts by weight, based on 100 parts by weight of the total of the decane compound.

較佳地,基於該矽烷化合物中所含的可水解基團為1莫耳,水的用量為0.5至100莫耳,更佳地為1至30莫耳。 Preferably, the water is used in an amount of from 0.5 to 100 moles, more preferably from 1 to 30 moles, based on 1 mole of hydrolyzable groups contained in the decane compound.

該催化劑可例如但不限於酸、鹼金屬化合物、有機鹼、鈦化合物,或鋯化合物。 The catalyst can be, for example but not limited to, an acid, an alkali metal compound, an organic base, a titanium compound, or a zirconium compound.

該酸可例如但不限於鹽酸、硝酸、硫酸、氟酸、草酸、磷酸、醋酸、三氟醋酸、蟻酸、多元羧酸、多元酸酐,或前述之一組合。 The acid can be, for example but not limited to, hydrochloric acid, nitric acid, sulfuric acid, hydrofluoric acid, oxalic acid, phosphoric acid, acetic acid, trifluoroacetic acid, formic acid, polycarboxylic acid, polybasic anhydride, or a combination of the foregoing.

該鹼金屬化合物可例如但不限於氫氧化鈉、氫氧化鉀、甲醇鈉、甲醇鉀、乙醇鈉、乙醇鉀等。 The alkali metal compound may be, for example but not limited to, sodium hydroxide, potassium hydroxide, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide or the like.

該有機鹼可例如但不限於乙胺、二乙胺、哌嗪、哌啶、吡咯啶、吡咯等一至二級有機胺;三乙胺、三正丙胺、三正丁胺、吡啶、4-二甲基胺基吡啶、二氮雜雙環十一烯等三級有機胺;四甲基氫氧化銨等四級有機胺。 The organic base may be, for example but not limited to, one to two organic amines such as ethylamine, diethylamine, piperazine, piperidine, pyrrolidine, pyrrole; triethylamine, tri-n-propylamine, tri-n-butylamine, pyridine, 4-di a tertiary organic amine such as methylaminopyridine or diazabicycloundecene; and a fourth organic amine such as tetramethylammonium hydroxide.

該催化劑的用量因種類、溫度等反應條件等而不同,應該適當設定。例如:基於全部的該矽烷化合物為1莫耳,該催化劑的用量較佳地為0.01至5莫耳,又較佳地為0.03至3莫耳,更佳地為0.05至1莫耳。 The amount of the catalyst used varies depending on the reaction conditions such as the type and temperature, and should be appropriately set. For example, the catalyst is preferably used in an amount of from 0.01 to 5 moles, more preferably from 0.03 to 3 moles, still more preferably from 0.05 to 1 mole, based on the total of the decane compound being 1 mole.

反應終止後,較佳地是將從反應溶液分取的有機溶劑層用水洗滌。更佳地是該反應溶液是用包含少量的鹽類的水洗滌,以使洗滌變得容易。例如:使用大約含有0.2wt%的硝酸銨水溶液來洗滌。洗滌進行到洗滌後的水層成為中性為止,其後依需要將該有機溶劑層用無水硫酸鈣、分子篩等乾燥劑乾燥後,去除溶劑,而可獲得該聚矽氧烷。 After the reaction is terminated, it is preferred to wash the organic solvent layer separated from the reaction solution with water. More preferably, the reaction solution is washed with water containing a small amount of salt to facilitate washing. For example: washing with an aqueous solution containing approximately 0.2% by weight of ammonium nitrate. The washing is carried out until the aqueous layer after washing becomes neutral. Thereafter, the organic solvent layer is dried with a desiccant such as anhydrous calcium sulfate or molecular sieve, and then the solvent is removed to obtain the polyoxyalkylene.

本發明該聚矽氧烷以凝膠滲透色層分析法(GPC)測量的重量平均分子量範圍為500至100,000,較佳地為800至50,000,更佳地為1,000至20,000。 The polyoxyalkylene of the present invention has a weight average molecular weight measured by gel permeation chromatography (GPC) ranging from 500 to 100,000, preferably from 800 to 50,000, more preferably from 1,000 to 20,000.

羧酸化合物Carboxylic acid compound

該羧酸化合物具有C4至C50的側鏈。較佳地,該羧酸化合物具有C6至C50的側鏈。 The carboxylic acid compound has a side chain of C 4 to C 50 . Preferably, the carboxylic acid compound has a side chain of from C 6 to C 50 .

該具有C4至C50之側鏈的羧酸化合物的具體例包含但不限於具有甾骨架的羧酸衍生物、由式(V)表示的化合物,或前述之一組合。 Specific examples of the compound having a carboxylic acid side chain of C 4 to C 50 comprising of but not limited to a carboxylic acid derivative having a steroid skeleton, a compound represented by the formula (V), or a combination of one of the foregoing.

B2-L0-L1-Z (V) B 2 -L 0 -L 1 -Z (V)

該具有甾骨架的羧酸衍生物的具體例包含但不限於具有甾骨架的苯甲酸衍生物、具有甾骨架的琥珀酸衍生物、由式(IV)表示的化合物,或前述之一組合。 Specific examples of the carboxylic acid derivative having an anthracene skeleton include, but are not limited to, a benzoic acid derivative having an anthracene skeleton, a succinic acid derivative having an anthracene skeleton, a compound represented by the formula (IV), or a combination of the foregoing.

在式(IV)中,n3為0至18的整數,X2為由式(X2-1)、式(X2-2)或式(X2-3)表示的基團: In formula (IV), n 3 is an integer from 0 to 18, X 2 by the Formula (X 2 -1), Formula (X 2 -2) or Formula (X 2 -3) a group represented by:

該具有甾骨架的羧酸衍生物的具體例包含但不限於膽甾烷氧基苯甲酸(cholestanyloxy benzoic acid)、膽甾烯氧基苯甲酸(cholestenyloxy benzoic acid)、羊毛甾烷基苯甲酸(lanostanyloxy benzoic acid)、膽甾烷氧基羰基苯甲酸(cholestanyloxy carbonyl benzoic acid)、膽甾烯氧基羰基苯甲酸(cholestenyloxy carbonyl benzoic acid)、羊毛甾烷基氧基羰基苯甲酸(lanostanyloxy carbonyl benzoic acid)、琥珀酸-5ξ-膽甾烷-3-基酯(5ξ-cholestane-3-yl succinate)、琥珀 酸-5ξ-膽甾烯-3-基酯(5ξ-cholestene-3-yl succinate)、琥珀酸-5ξ-羊毛甾烷-3-基醋(5ξ-lanostane-3-yl succinate)、由式(IV-1)表示的化合物、由式(IV-2)表示的化合物,或上述化合物的組合。 Specific examples of the carboxylic acid derivative having an anthracene skeleton include, but are not limited to, cholestanyloxy benzoic acid, cholestenyloxy benzoic acid, lanostanyl benzoic acid (lanostanyloxy) Benzoic acid), cholestanyloxy carbonyl benzoic acid, cholestenyloxy carbonyl benzoic acid, lanostanyloxy carbonyl benzoic acid, Succinic acid-5ξ-cholestane-3-yl ester (5ξ-cholestane-3-yl succinate), amber Acid-5ξ-cholestene-3-yl succinate, succinic acid-5ξ-lanostane-3-yl vinegar (5ξ-lanostane-3-yl succinate), by formula ( A compound represented by IV-1), a compound represented by the formula (IV-2), or a combination of the above compounds.

B2-L0-L1-Z (V) B 2 -L 0 -L 1 -Z (V)

於式(V)中,B2表示C4至C50的直鏈烷基或支鏈烷基。上述烷基的氫原子的一部分或全部可經氰基、氟原子、三氟甲基等取代基取代。 In the formula (V), B 2 represents a linear alkyl group or a branched alkyl group of C 4 to C 50 . A part or all of the hydrogen atom of the above alkyl group may be substituted with a substituent such as a cyano group, a fluorine atom or a trifluoromethyl group.

當B2表示C4至C50的直鏈烷基或支鏈烷基的具體例是包含但不限於正丁基、第二丁基、第三丁基、正戊基、3-甲基丁基、2-甲基丁基、1-甲基丁基、2,2-二甲基丙基、正己基、4-甲基戊基、3-甲基戊基、2-甲基戊基、1-甲基戊基、3,3-二甲基丁基、2,3-二甲基丁基、1,3-二甲基丁基、2,2-二甲基丁基、1,2-二甲基丁基、1,1-二甲基丁基、 正庚基、5-甲基己基、4-甲基己基、3-甲基己基、2-甲基己基、1-甲基己基、4,4-二甲基戊基、3,4-二甲基戊基、2,4-二甲基戊基、1,4-二甲基戊基、3,3-二甲基戊基、2,3-二甲基戊基、1,3-二甲基戊基、2,2-二甲基戊基、1,2-二甲基戊基、1,1-二甲基戊基、2,3,3-三甲基丁基、1,3,3-三甲基丁基、1,2,3-三甲基丁基、正辛基、6-甲基庚基、5-甲基庚基、4-甲基庚基、3-甲基庚基、2-甲基庚基、1-甲基庚基、2-乙基己基、正壬基、正癸基、正十一烷基、正十二烷基、正十三烷基、正十四烷基、正十五烷基、正十六烷基、正十七烷基、正十八烷基,或正十九烷基等。 Specific examples of the linear alkyl or branched alkyl group in which B 2 represents C 4 to C 50 include, but are not limited to, n-butyl group, second butyl group, tert-butyl group, n-pentyl group, and 3-methyl group. Base, 2-methylbutyl, 1-methylbutyl, 2,2-dimethylpropyl, n-hexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 1,2 - dimethylbutyl, 1,1-dimethylbutyl, n-heptyl, 5-methylhexyl, 4-methylhexyl, 3-methylhexyl, 2-methylhexyl, 1-methylhexyl 4,4-Dimethylpentyl, 3,4-dimethylpentyl, 2,4-dimethylpentyl, 1,4-dimethylpentyl, 3,3-dimethylpentyl , 2,3-dimethylpentyl, 1,3-dimethylpentyl, 2,2-dimethylpentyl, 1,2-dimethylpentyl, 1,1-dimethylpentyl , 2,3,3-trimethylbutyl, 1,3,3-trimethylbutyl, 1,2,3-trimethylbutyl, n-octyl, 6-methylheptyl, 5- Methyl heptyl, 4-methylheptyl, 3-methylheptyl, 2-methylheptyl, 1-methylheptyl, 2-ethylhexyl, n-decyl, n-decyl, n. Alkyl, n-dodecane , N-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, or n-nonadecyl group.

較佳地,於式(V)中,B2表示C6至C50的直鏈烷基或支鏈烷基,或C6至C50的直鏈氯烷基或支鏈氯烷基。 Preferably, in the formula (V), B 2 represents a C 6 to C 50 linear alkyl group or a branched alkyl group, or a C 6 to C 50 linear chloroalkyl group or a branched chloroalkyl group.

L0表示單鍵或*-O-,其中「*」表示與B2鍵結的位置。 L 0 represents a single bond or * -O-, wherein "*" represents a bonding position B 2.

L1表示單鍵、伸苯基、伸聯苯基、伸環己基、伸二環己基,或者由式(L1-1)或式(L1-2)表示的基: 其中,*表示與Z鍵結的位置,且Z表示羧酸基。 L 1 represents a single bond, a phenylene group, a stretched biphenyl group, a cyclohexylene group, a dicyclohexyl group, or a group represented by the formula (L 1 -1) or the formula (L 1 -2): Wherein * represents the position bonded to Z, and Z represents a carboxylic acid group.

當L1是單鍵時,L0是單鍵。 When L 1 is a single bond, L 0 is a single bond.

較佳的,如式(V)所示的化合物是選自於由式(V-1)至式(V-5)表示的化合物: H2W+1Cw-COOH (V-1)、 F2u+1Cu-CvH2v-COOH (V-3)、 Preferably, the compound represented by the formula (V) is selected from the compounds represented by the formula (V-1) to the formula (V-5): H 2W+1 C w -COOH (V-1), F 2u+1 C u -C v H 2v -COOH (V-3),

其中,u表示1至5的整數,v表示1至18的整數,u+v≧4,w表示4至20的整數,p表示0或1,r表示0至18的整數,u+r≧4,及s及t各自表示0至2的整數。 Wherein u represents an integer from 1 to 5, v represents an integer from 1 to 18, u+v≧4, w represents an integer from 4 to 20, p represents 0 or 1, and r represents an integer from 0 to 18, u+r≧ 4, and s and t each represent an integer of 0 to 2.

式(V-1)至(V-5)的具體例包含但不限於戊酸、己酸、正庚酸、正辛酸、正癸酸、正十二酸、正十六酸、硬脂酸、正己基苯甲酸、4-正辛基苯甲酸、4-正癸基苯甲酸、4-正十二烷基苯甲酸、4-正十六烷基苯甲酸、4-十八烷基苯甲酸、4-正己氧基苯甲酸、4-正辛氧基苯甲酸、4-正癸氧基苯甲酸、4-正十二烷氧基苯甲酸、4-正十六烷氧基苯甲酸、4-十八烷氧基苯甲酸、4-(4-戊基-環己基)苯甲酸、4-(4-己基-環己基)苯甲酸、4-(4-庚基-環己基)苯甲酸、4’-戊基-二 環己基-4-羧酸、4’-己基-二環己基-4-羧酸、4’-庚基-二環己基-4-羧酸、4’-戊基-聯苯-4-羧酸(4’-pentyl-biphenyl-4-carboxylic acid)、4’-己基-聯苯-4-羧酸、4’-庚基-聯苯-4-羧酸、4-(4-戊基-二環己基-4-基)苯甲酸、4-(4-己基-二環己基-4-基)苯甲酸、4-(4-庚基-二環己基-4-基)苯甲酸、由式(V-6)至式(V-8)表示的化合物中的至少一種,或前述之一組合。 Specific examples of the formulae (V-1) to (V-5) include, but are not limited to, valeric acid, caproic acid, n-heptanoic acid, n-octanoic acid, n-decanoic acid, n-dodecanoic acid, n-hexadecanoic acid, stearic acid, N-hexylbenzoic acid, 4-n-octylbenzoic acid, 4-n-decylbenzoic acid, 4-n-dodecylbenzoic acid, 4-n-hexadecylbenzoic acid, 4-octadecylbenzoic acid, 4-n-hexyloxybenzoic acid, 4-n-octyloxybenzoic acid, 4-n-decyloxybenzoic acid, 4-n-dodecyloxybenzoic acid, 4-n-hexadecyloxybenzoic acid, 4- Octadecyloxybenzoic acid, 4-(4-pentyl-cyclohexyl)benzoic acid, 4-(4-hexyl-cyclohexyl)benzoic acid, 4-(4-heptyl-cyclohexyl)benzoic acid, 4 '-pentyl-two Cyclohexyl-4-carboxylic acid, 4'-hexyl-dicyclohexyl-4-carboxylic acid, 4'-heptyl-dicyclohexyl-4-carboxylic acid, 4'-pentyl-biphenyl-4-carboxylic acid (4'-pentyl-biphenyl-4-carboxylic acid), 4'-hexyl-biphenyl-4-carboxylic acid, 4'-heptyl-biphenyl-4-carboxylic acid, 4-(4-pentyl-di Cyclohexyl-4-yl)benzoic acid, 4-(4-hexyl-dicyclohexyl-4-yl)benzoic acid, 4-(4-heptyl-dicyclohexyl-4-yl)benzoic acid, V-6) to at least one of the compounds represented by the formula (V-8), or a combination of the foregoing.

F3C-C3H6-COOH (V-6)、 F 3 CC 3 H 6 -COOH (V-6),

較佳地,該具有C4至C50側鏈的羧酸化合物的具體例包含但不限於膽甾烷氧基苯甲酸、膽甾烷氧基羰基苯甲酸、由式(IV-1)表示的化合物、戊酸、己酸、正庚酸、正辛酸、正十六酸、硬脂酸、正己基苯甲酸、4-正十二烷基苯甲酸、4-正己氧基苯甲酸、4-十八烷氧基苯甲酸、4-(4-戊基-環己基)苯甲酸、4’-戊基-二環己基-4-羧酸、4’-戊基-聯苯-4-羧酸、4-(4-己基-二環己基-4-基)苯甲酸、由式(V-6)表示的化合物、由式(V-7)表示的化合物,或前述之一組合。 Preferably, specific examples of the carboxylic acid compound having a C 4 to C 50 side chain include, but are not limited to, cholestyloxybenzoic acid, cholestyloxycarbonylbenzoic acid, represented by the formula (IV-1) Compound, valeric acid, caproic acid, n-heptanoic acid, n-octanoic acid, n-hexadecanoic acid, stearic acid, n-hexylbenzoic acid, 4-n-dodecylbenzoic acid, 4-n-hexyloxybenzoic acid, 4-ten Octaoxybenzoic acid, 4-(4-pentyl-cyclohexyl)benzoic acid, 4'-pentyl-dicyclohexyl-4-carboxylic acid, 4'-pentyl-biphenyl-4-carboxylic acid, 4-(4-hexyl-dicyclohexyl-4-yl)benzoic acid, a compound represented by the formula (V-6), a compound represented by the formula (V-7), or a combination of the foregoing.

較佳地,該具有C4至C50側鏈的羧酸化合物及該由式(III)所示的第一矽烷化合物的莫耳當量用量範圍是0.2至1.2,又較佳地是0.3至1.1,更佳地是0.4至1.0。 Preferably, the molar equivalent amount of the carboxylic acid compound having a C 4 to C 50 side chain and the first decane compound represented by the formula (III) is in the range of 0.2 to 1.2, and more preferably 0.3 to 1.1. More preferably, it is 0.4 to 1.0.

當該液晶配向劑含有該具有C6至C50側鏈的羧 酸化合物,含有由該液晶配向劑形成的液晶配向膜的液晶顯示元件在紫外線照射後會具有較佳的電壓保持率。 When the liquid crystal alignment agent contains the carboxylic acid compound having a C 6 to C 50 side chain, the liquid crystal display element containing the liquid crystal alignment film formed of the liquid crystal alignment agent has a preferable voltage holding ratio after ultraviolet irradiation.

製備該聚矽氧烷的方法Method for preparing the polyoxyalkylene

該聚矽氧烷是由將該含有環氧基基團的聚矽氧烷化合物及該具有C4至C50之側鏈的羧酸化合物於一溶劑及在一催化劑的存在下進行反應所製得。 The polyoxyalkylene is produced by reacting the epoxy group-containing polyoxyalkylene compound and the carboxylic acid compound having a C 4 to C 50 side chain in a solvent and in the presence of a catalyst. Got it.

該溶劑並無特別的限制,可以與製備該含有環氧基基團的聚矽氧烷化合物的溶劑為相同或不同。較佳地,該溶劑的具體例為2-丁酮、2-己酮、甲基異丁基酮、醋酸正丁酯,或前述的一組合。 The solvent is not particularly limited and may be the same as or different from the solvent for preparing the epoxy group-containing polyoxyalkylene compound. Preferably, specific examples of the solvent are 2-butanone, 2-hexanone, methyl isobutyl ketone, n-butyl acetate, or a combination of the foregoing.

該催化劑並無特別的限制,可以與製備該含有環氧基基團的聚矽氧烷化合物的催化劑為相同或不同,亦可以使用一硬化促進劑。 The catalyst is not particularly limited and may be the same as or different from the catalyst for preparing the epoxy group-containing polyoxyalkylene compound, and a curing accelerator may also be used.

該硬化促進劑是一個可以促進該含有環氧基基團的聚矽氧烷化合物及該具有C4-C50之側鏈的羧酸化合物反應的化合物。該硬化促進劑的具體例包含但不限於三級胺例如苄基二甲基胺、2,4,6-三(二甲基胺基甲基)苯酚、環己基二甲基胺、三乙醇胺;咪唑化合物例如2-甲基咪唑、2-正庚基咪唑、2-正十一烷基咪唑、2-苯基咪唑、2-苯基-4-甲基咪唑、1-苄基-2-甲基咪唑、1-苄基-2-苯基咪唑、1,2-二甲基咪唑、2-乙基-4-甲基咪唑、1-(2-氰基乙基)-2-甲基咪唑、1-(2-氰基乙基)-2-正十一烷基咪唑、1-(2-氰基乙基)-2-苯基咪唑、1-(2-氰基乙基)-2-乙基-4-甲基唑唑、2-苯基-4-甲基-5-羥甲基咪唑、2-苯基-4,5-二(羥甲基)咪唑、1-(2- 氰基乙基)-2-苯基-4,5-二[(2’-氰基乙氧基)甲基]咪唑、1-(2-氰基乙基)-2-正十一烷基咪唑鎓苯偏三酸鹽(1-(2-cyanoethyl)-2-n-undecanyl imidazolium trimellitate)、1-(2-氰基乙基)-2-苯基咪唑鎓苯偏三酸鹽、1-(2-氰基乙基)-2-乙基-4-甲基咪唑鎓苯偏三酸鹽、2,4-二胺基-6-[2’-甲基咪唑基-(1’)]乙基-s-三嗪、2,4-二胺基-6-(2’-正十一烷基咪唑基)乙基-s-三嗪、2,4-二胺基-6-[2’-乙基-4’-甲基咪唑基-(1’)]乙基-s-三嗪、2-甲基咪唑的異氰脲酸加成物、2-苯基咪唑的異氰脲酸加成物、2,4-二胺基-6-[2’-甲基咪唑基-(1’)]乙基-s-三嗪的異氰脲酸加成物;有機磷化合物例如二苯基膦、三苯基膦、亞磷酸三苯基酯;四級鏻鹽例如苄基三苯基氯化鏻(benzyl triphenyl phosphonium chloride)、四正丁基溴化鏻、甲基三苯基溴化鏻、乙基三苯基溴化鏻、正丁基三苯基溴化鏻、四苯基溴化鏻、乙基三苯基碘化鏻、乙基三苯基鏻乙酸鹽、四正丁基鏻O,O-二乙基偶磷二硫代硫酸鹽、四正丁基鏻苯并三唑鹽、四正丁基鏻四氟硼酸鹽、四正丁基鏻四苯基硼酸鹽、四苯基鏻四苯基硼酸鹽等;二氮雜雙環烯烴例如1,8-二氮雜雙環[5.4.0]十一烯-7及其有機酸鹽;有機金屬化合物例如辛酸鋅、辛酸錫、乙醯丙酮鋁錯合物(aluminium acetylacetone complex);四級銨鹽例如四乙基溴化銨、四正丁基溴化銨、四乙基氯化銨、四正丁基氯化銨;硼化合物例如三氟化硼、硼酸三苯基酯;金屬鹵化物例如氯化鋅、氯化錫;高熔點分散型潛在性硬化促進劑例如二氰基二醯胺或胺和環氧樹脂的加成物等的胺加成型促進劑;微膠囊型 潛在性硬化促進劑例如由上述咪唑化合物、有機磷化合物以及四級鏻鹽等硬化促進劑的表面用聚合物包覆所形成;胺鹽型潛在性硬化促進劑;高溫分解型熱陽離子聚合型潛在性硬化促進劑例如路易士酸鹽、布忍斯特酸(Bronsted acid)鹽。 The hardening accelerator is a compound which can promote the reaction of the epoxy group-containing polyoxyalkylene compound and the carboxylic acid compound having a C 4 -C 50 side chain. Specific examples of the hardening accelerator include, but are not limited to, tertiary amines such as benzyldimethylamine, 2,4,6-tris(dimethylaminomethyl)phenol, cyclohexyldimethylamine, triethanolamine; Imidazole compounds such as 2-methylimidazole, 2-n-heptyl imidazole, 2-n-undecylimidazole, 2-phenylimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-methyl Imidazole, 1-benzyl-2-phenylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 1-(2-cyanoethyl)-2-methylimidazole , 1-(2-cyanoethyl)-2-n-undecylimidazole, 1-(2-cyanoethyl)-2-phenylimidazole, 1-(2-cyanoethyl)-2 -ethyl-4-methyloxazol, 2-phenyl-4-methyl-5-hydroxymethylimidazole, 2-phenyl-4,5-bis(hydroxymethyl)imidazole, 1-(2- Cyanoethyl)-2-phenyl-4,5-bis[(2'-cyanoethoxy)methyl]imidazole, 1-(2-cyanoethyl)-2-n-undecyl 1-(2-cyanoethyl)-2-n-undecanyl imidazolium trimellitate, 1-(2-cyanoethyl)-2-phenylimidazolium benzoate, 1- (2-cyanoethyl)-2-ethyl-4-methylimidazolium benzoate, 2,4-diamino-6-[2'-methylimidazolyl-(1')] Ethyl-s-triazine, 2,4- Diamino-6-(2'-n-undecylimidazolyl)ethyl-s-triazine, 2,4-diamino-6-[2'-ethyl-4'-methylimidazolyl -(1')]ethyl-s-triazine, isocyanuric acid addition of 2-methylimidazole, isocyanuric acid addition of 2-phenylimidazole, 2,4-diamino- An isocyanuric acid adduct of 6-[2'-methylimidazolyl-(1')]ethyl-s-triazine; an organophosphorus compound such as diphenylphosphine, triphenylphosphine, triphenylphosphite a quaternary phosphonium salt such as benzyl triphenyl phosphonium chloride, tetra-n-butylphosphonium bromide, methyltriphenylphosphonium bromide, ethyltriphenylphosphonium bromide, positive Butyl triphenylphosphonium bromide, tetraphenylphosphonium bromide, ethyltriphenylphosphonium iodide, ethyltriphenylphosphonium acetate, tetra-n-butylphosphonium O, O-diethylphosphonium disulfide Sulfate, tetra-n-butylphosphonium benzotriazole salt, tetra-n-butylphosphonium tetrafluoroborate, tetra-n-butylphosphonium tetraphenylborate, tetraphenylphosphonium tetraphenylborate, etc.; Bicyclic olefins such as 1,8-diazabicyclo[5.4.0]undecene-7 and organic acid salts thereof; organometallic compounds such as zinc octoate, tin octoate, aluminum acetonate complex (alumi) Nium acetylacetone complex); quaternary ammonium salts such as tetraethylammonium bromide, tetra-n-butylammonium bromide, tetraethylammonium chloride, tetra-n-butylammonium chloride; boron compounds such as boron trifluoride, boric acid a phenyl ester; a metal halide such as zinc chloride or tin chloride; a high melting point dispersion type latent hardening accelerator such as dicyanodiamine or an amine addition accelerator of an amine and an epoxy resin; The microcapsule-type latent curing accelerator is formed, for example, by coating a surface of a hardening accelerator such as the above-described imidazole compound, organophosphorus compound, or quaternary phosphonium salt with a polymer; an amine salt type latent curing accelerator; a pyrolysis type thermal cation; A polymeric latent hardening accelerator such as Lewis acid salt or Bronsted acid salt.

在前述中,較佳地為四乙基溴化銨、四正丁基溴化銨、四乙基氯化銨、四正丁基氯化銨等四級銨鹽。 Among the foregoing, a quaternary ammonium salt such as tetraethylammonium bromide, tetra-n-butylammonium bromide, tetraethylammonium chloride or tetra-n-butylammonium chloride is preferred.

基於該具有C4至C50之側鏈的羧酸化合物的用量為100重量份,該催化劑的用量為不大於100重量份,較佳為0.01至100重量份,更佳地為0.1至20重量份。 Based on the amount of the carboxylic acid compound having a C 4 to C 50 side chain of the 100 parts by weight, the amount of catalyst is not more than 100 parts by weight, preferably 0.01 to 100 parts by weight, more preferably 0.1 to 20 wt. Share.

該反應溫度的範圍較佳地為0至200℃,更加地為50至150℃。反應時間的範圍較佳地為0.1至50小時且更佳地為0.5至20小時。 The reaction temperature is preferably in the range of 0 to 200 ° C, more preferably 50 to 150 ° C. The reaction time is preferably in the range of 0.1 to 50 hours and more preferably 0.5 to 20 hours.

溶劑Solvent

用於本發明液晶配向劑的該溶劑並無特別的限制,只要能將該聚合物組成物及該聚矽氧烷分散或溶解即可。該溶劑包含但不限於氮-甲基-2-吡咯烷酮[N-methyl-2-pyrrolidone]、γ-丁內酯、γ-丁內醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚[ethylene glycol n-butyl ether]、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二甘醇二甲基醚、二甘醇二乙基醚、二甘醇單甲基醚、二甘醇單乙基醚、二甘醇單甲基醚 乙酸酯、二甘醇單乙基醚乙酸酯、氮,氮-二甲基甲醯胺,或氮,氮-二甲基乙醯胺[N,N-dimethylethanamide]。該液晶配向劑中所使用的溶劑可單獨使用一種或混合複數種使用。 The solvent used in the liquid crystal alignment agent of the present invention is not particularly limited as long as the polymer composition and the polyoxyalkylene oxide can be dispersed or dissolved. The solvent includes, but is not limited to, nitrogen-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactam, 4-hydroxy-4-methyl-2-pentanone , ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxy propionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol Propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol Ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether Acetate, diethylene glycol monoethyl ether acetate, nitrogen, nitrogen-dimethylformamide, or nitrogen, N-N-dimethylethanamide. The solvent used in the liquid crystal alignment agent may be used singly or in combination of plural kinds.

較佳地,基於100重量份的該聚合物組成物,該溶劑的使用量範圍為1,000重量份至2,000重量份;更佳地,該溶劑的使用量範圍為1,200重量份至2,000重量份。 Preferably, the solvent is used in an amount ranging from 1,000 parts by weight to 2,000 parts by weight based on 100 parts by weight of the polymer composition; more preferably, the solvent is used in an amount ranging from 1,200 parts by weight to 2,000 parts by weight.

添加劑additive

在不影響本發明之功效範圍內,該液晶配向劑還包含一添加劑,且該添加劑為一分子中具有至少兩個環氧基的化合物或含有官能性基團的矽烷化合物等。該添加劑可以單獨一種使用或者混合複數種使用。 The liquid crystal alignment agent further contains an additive, and the additive is a compound having at least two epoxy groups in one molecule or a decane compound containing a functional group, and the like, within a range not impairing the efficacy of the present invention. The additives may be used singly or in combination of plural kinds.

該含有官能性基團的矽烷化合物的具體例包含但不限於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、氮-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、氮-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、氮-乙氧基羰基-3-胺基丙基三甲氧基矽烷、氮-乙氧基羰基-3-胺基丙基三乙氧基矽烷、氮-三乙氧基矽烷基丙基三伸乙三胺、氮-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、氮-苯甲基-3-胺基丙基三甲氧基矽烷、氮-苯甲基-3-胺基丙基三乙氧基矽烷、氮-苯基-3-胺基丙基三甲氧基矽烷、氮- 苯基-3-胺基丙基三乙氧基矽烷、氮-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、氮-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷等。 Specific examples of the functional group-containing decane compound include, but are not limited to, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-Aminopropyltriethoxydecane, nitrogen-(2-aminoethyl)-3-aminopropyltrimethoxydecane, nitrogen-(2-aminoethyl)-3-aminopropyl Methyl dimethoxy decane, 3-ureidopropyl trimethoxy decane, 3-ureidopropyl triethoxy decane, nitrogen-ethoxycarbonyl-3-aminopropyl trimethoxy decane, Nitrogen-ethoxycarbonyl-3-aminopropyltriethoxydecane, nitrogen-triethoxydecylpropyltriamine, nitrogen-trimethoxydecylpropyltriamine, 10-trimethoxydecyl-1,4,7-trioxane, 10-triethoxydecyl-1,4,7-trioxane, 9-trimethoxydecyl-3,6 - Dimercaptoacetate, 9-triethoxydecyl-3,6-dimercaptoacetate, nitrogen-benzyl-3-aminopropyltrimethoxydecane, nitrogen-benzyl 3-aminopropyltriethoxydecane, nitrogen-phenyl-3-aminopropyltrimethoxydecane, nitrogen- Phenyl-3-aminopropyltriethoxydecane, nitrogen-bis(oxyethylene)-3-aminopropyltrimethoxydecane, nitrogen-bis(ethylene oxide)-3-aminopropyltriethyl Oxydecane, etc.

基於該聚合物組成物為100重量份,該含有官能性基團的矽烷化合物的使用量範圍為0重量份至10重量份;較佳地,該含有官能性基團的矽烷化合物的使用量範圍為0.5重量份至10重量份。 The functional group-containing decane compound is used in an amount ranging from 0 parts by weight to 10 parts by weight based on 100 parts by weight of the polymer composition; preferably, the functional group-containing decane compound is used in an amount ranging It is from 0.5 part by weight to 10 parts by weight.

該一分子中具有至少兩個環氧基的化合物的具體例包含但不限於乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、氮,氮,氮’,氮’-四環氧丙基-間-二甲苯二胺、1,3-雙(氮,氮-二環氧丙基胺基甲基)環己烷、氮,氮,氮’,氮’-四環氧丙基-4,4'-二胺基二苯基甲烷、氮,氮-環氧丙基-對-環氧丙氧基苯胺、3-(氮,氮-二環氧丙基)胺基丙基三甲氧基矽烷]等。 Specific examples of the compound having at least two epoxy groups in the molecule include, but are not limited to, ethylene glycol diepoxypropyl ether, polyethylene glycol diepoxypropyl ether, propylene glycol diepoxypropyl ether, and three Propylene glycol diepoxypropyl ether, polypropylene glycol diepoxypropyl ether, neopentyl glycol diepoxypropyl ether, 1,6-hexanediol diepoxypropyl ether, glycerol diepoxypropyl Ether, 2,2-dibromo neopentyl glycol diepoxypropyl ether, 1,3,5,6-tetraepoxypropyl-2,4-hexanediol, nitrogen, nitrogen, nitrogen ', nitrogen' -tetraethoxypropyl-m-xylylenediamine, 1,3-bis(nitrogen, nitrogen-diepoxypropylaminomethyl)cyclohexane, nitrogen, nitrogen, nitrogen ', nitrogen'-tetracyclic Oxypropyl-4,4'-diaminodiphenylmethane, nitrogen, nitrogen-glycidyl-p-glycidoxyaniline, 3-(nitrogen, nitrogen-diepoxypropyl)amino Propyltrimethoxydecane] and the like.

基於該聚合物組成物為100重量份,該一分子中具有至少兩個環氧基的化合物的使用量可為0至40重量份,且較佳為0.1重量份至30重量份。 The compound having at least two epoxy groups in the molecule may be used in an amount of from 0 to 40 parts by weight, and preferably from 0.1 part by weight to 30 parts by weight, based on 100 parts by weight of the polymer composition.

較佳地,基於該聚合物組成物為100重量份,該添加劑的用量為0.5至50重量份,更佳地為1至45重量份。 Preferably, the additive is used in an amount of from 0.5 to 50 parts by weight, more preferably from 1 to 45 parts by weight, based on 100 parts by weight of the polymer composition.

製造本發明液晶配向劑的方法並沒有特別限制 ,可以使用一般的混和方法。例如,本發明液晶配向劑的先將聚醯胺酸聚合物、聚醯亞胺聚合物,或選擇性地添加聚醯亞胺系嵌段共聚合物混合均勻,形成一聚合物組成物,接著,再將該聚合物於溫度為0℃至200℃,較佳地為20至60℃的條件下加入該聚矽氧烷、溶劑,且選擇性地添加該添加劑,並持續攪拌至溶解即可。 The method for producing the liquid crystal alignment agent of the present invention is not particularly limited You can use the general blending method. For example, the liquid crystal alignment agent of the present invention firstly mixes a polyamic acid polymer, a polyamidene polymer, or a selective polyamidene block copolymer to form a polymer composition, and then forms a polymer composition. And adding the polymer to the polyoxoxane, the solvent at a temperature of 0 ° C to 200 ° C, preferably 20 to 60 ° C, and optionally adding the additive, and continuously stirring until dissolved .

液晶配向膜Liquid crystal alignment film

本發明液晶配向膜,係由一如上所述之液晶配向劑所形成。 The liquid crystal alignment film of the present invention is formed by a liquid crystal alignment agent as described above.

該液晶配向膜的形成方式包含之步驟為:將上述之液晶配向劑利用輥塗佈法、旋轉塗佈法、印刷法、噴墨法(ink-jet)等方法,塗佈在一基材的表面上,形成一預塗層,接著將該預塗層經過預先加熱處理(pre-bake treatment)、後加熱處理(post-bake treatment)及配向處理(alignment treatment)而製得。 The liquid crystal alignment film is formed by coating the liquid crystal alignment agent on a substrate by a roll coating method, a spin coating method, a printing method, an inkjet method, or the like. On the surface, a precoat layer is formed, which is then obtained by subjecting the precoat layer to a pre-bake treatment, a post-bake treatment, and an alignment treatment.

該預先加熱處理目的在於使該預塗層中的溶劑揮發。較佳地,該預先加熱處理的操作溫度範圍為30℃至120℃,更佳地為40℃至110℃,又更佳地為50℃至100℃。 The preheating treatment aims to volatilize the solvent in the precoat layer. Preferably, the preheating treatment has an operating temperature in the range of 30 ° C to 120 ° C, more preferably 40 ° C to 110 ° C, still more preferably 50 ° C to 100 ° C.

後加熱處理步驟目的在於使該預塗層中的聚合物再進一步進行脫水閉環(醯亞胺化)反應。較佳地,該後加熱處理的操作溫度範圍為150℃至300℃,更佳地為180℃至280℃,又更佳地為200℃至250℃。 The post-heat treatment step is aimed at further subjecting the polymer in the precoat layer to a dehydration ring-closing (deuteration) reaction. Preferably, the post-heat treatment has an operating temperature in the range of from 150 ° C to 300 ° C, more preferably from 180 ° C to 280 ° C, still more preferably from 200 ° C to 250 ° C.

該配向處理並無特別的限制,可採用尼龍、人 造絲、棉類等纖維所做成的布料纏繞在滾筒上,以一定方向磨擦進行配向。上述配向處理為本技術領域者所周知,因此不再贅述。 There is no special restriction on the alignment treatment, and nylon and human can be used. The fabric made of fibers such as silk and cotton is wound around the drum and rubbed in a certain direction for alignment. The above alignment processing is well known to those skilled in the art, and therefore will not be described again.

液晶顯示元件Liquid crystal display element

如圖1所式,,本發明液晶顯示元件的較佳實施例是包含一第一單元11、一與第一單元間隔相對的第二單元12,及一夾置在該第一單元11與第二單元12之間的液晶單元13。 As shown in FIG. 1, a preferred embodiment of the liquid crystal display device of the present invention includes a first unit 11, a second unit 12 spaced apart from the first unit, and a first unit 11 and a first unit The liquid crystal cell 13 between the two cells 12.

該第一單元11包括一第一基板111、一形成於該第一基板111表面的第一導電膜112,及一形成在該第一導電膜112表面且相對於該第一基板111的第一液晶配向膜113。 The first unit 11 includes a first substrate 111, a first conductive film 112 formed on the surface of the first substrate 111, and a first surface formed on the first conductive film 112 and opposite to the first substrate 111. Liquid crystal alignment film 113.

該第二單元12包括一第二基板121、一形成於該第二基板121表面的第二導電膜122,及一形成在該第二導電膜122表面且相對於該第二基板121的第二液晶配向膜123。 The second unit 12 includes a second substrate 121, a second conductive film 122 formed on the surface of the second substrate 121, and a second surface formed on the surface of the second conductive film 122 and opposite to the second substrate 121. Liquid crystal alignment film 123.

適用於本發明的該第一基板111與第二基板121是擇自於一透明材料等,例如用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等。該第一導電膜112與第二導電膜122的材質是擇自於氧化錫(SnO2)、氧化銦-氧化錫(In2O3-SnO2)等。 The first substrate 111 and the second substrate 121 suitable for use in the present invention are selected from a transparent material or the like, such as an alkali-free glass, a soda-lime glass, a hard glass (Pyrus glass), a quartz glass for a liquid crystal display device. , polyethylene terephthalate, polybutylene terephthalate, polyether oxime, polycarbonate, and the like. The material of the first conductive film 112 and the second conductive film 122 is selected from tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 -SnO 2 ), or the like.

該第一液晶配向膜113及第二液晶配向膜123分別為上述之液晶配向膜,其作用在於使該液晶單元13形 成一預傾角。該液晶單元13可被該第一導電膜112與第二導電膜122配合產生的電場驅動。 The first liquid crystal alignment film 113 and the second liquid crystal alignment film 123 are respectively the liquid crystal alignment film described above, and the function thereof is to shape the liquid crystal cell 13 Into a pretilt angle. The liquid crystal cell 13 can be driven by an electric field generated by the cooperation of the first conductive film 112 and the second conductive film 122.

該液晶單元13所使用的液晶包含但不限於二胺基苯類液晶(diaminobenzene liquid crystals)、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff Base)類液晶、氧化偶氮基(azoxy)類液晶、聯苯類液晶、苯基環己烷類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶、立方烷(cubane)類液晶等,且可視需求再添加如氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶,或是以商品名為「C-15」、「CB-15」(默克公司製造)的對掌(chiral)劑等,或者是對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強誘電性(ferroelectric)類液晶。前述液晶可以單獨使用,或混合兩種或複數種使用。 The liquid crystal used in the liquid crystal cell 13 includes, but is not limited to, diaminobenzene liquid crystals, pyridazine liquid crystals, shiff base liquid crystals, and azoxy groups. Liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, phenylcyclohexane liquid crystal, ester liquid crystal, terphenyl, biphenylcyclohexane liquid crystal a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a cubane liquid crystal, etc., and optionally, such as cholesteryl chloride, Cholesterol-type liquid crystals such as cholesterol cholesteryl carbonate and cholesterol ester carbonate, or chiral products (trade name "C-15" and "CB-15" (made by Merck) Or a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate. The foregoing liquid crystals may be used singly or in combination of two or more.

本發明將就以下實施例來作進一步說明,但應瞭解的是,該實施例僅為例示說明之用,而不應被解釋為本發明實施之限制。 The present invention will be further illustrated by the following examples, but it should be understood that this embodiment is intended to be illustrative only and not to be construed as limiting.

實施例Example [製備聚合物組成物][Preparation of polymer composition] [製備聚醯胺酸化合物][Preparation of poly-proline compounds] 合成例1Synthesis Example 1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣,加入式(I-11)之第一二胺化合物(4.44克,0.0075莫耳)(b-1-1)、式(II-10)之第二二胺化合物(1.16克,0.0025莫耳)(b-2-1)、對-二胺苯(4.32克,0.04莫耳)(b-3-1)、及氮-甲基-2-吡咯烷酮(80克),於室溫下攪拌至溶解。再加入2,3,5-三羧基環戊基醋酸二酐(11.2g,0.05莫耳)(a1-1)及氮-甲基-2-吡咯烷酮(20克),於室溫下反應2小時。反應結束後,將反應液倒入(1500毫升)水中將聚合物析出,過濾所得之聚合物重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,獲得聚合物組成物(A-1-1)。 A nitrogen inlet, a stirrer, a condenser and a thermometer were placed on a four-necked conical flask having a volume of 500 ml, and nitrogen gas was introduced, and the first diamine compound of the formula (I-11) (4.44 g, 0.0075 mol) was added (b). -1-1), a second diamine compound of formula (II-10) (1.16 g, 0.0025 mol) (b-2-1), p-diamine benzene (4.32 g, 0.04 mol) (b- 3-1), and nitrogen-methyl-2-pyrrolidone (80 g) were stirred at room temperature until dissolved. Further, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride (11.2 g, 0.05 mol) (a1-1) and nitrogen-methyl-2-pyrrolidone (20 g) were added and reacted at room temperature for 2 hours. . After the reaction was completed, the reaction liquid was poured into (1500 ml) of water to precipitate a polymer. The polymer obtained by filtration was repeatedly washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60 ° C to obtain a polymer composition. (A-1-1).

合成例2至5及合成比較例1至3及6Synthesis Examples 2 to 5 and Synthesis Comparative Examples 1 to 3 and 6

合成例2至5及合成比較例1至3及6是以與合成例1相同的步驟來製備該聚合物組成物(A-1-2)至(A-1-5),(A-3-1)至(A-3-3)及(A-3-6)不同的地方在於:改變四羧酸二酐化合物、二胺化合物的種類及其用量,如表1及表2所示。 Synthesis Examples 2 to 5 and Synthesis Comparative Examples 1 to 3 and 6 were prepared in the same manner as in Synthesis Example 1 to prepare the polymer compositions (A-1-2) to (A-1-5), (A-3) The difference between -1) and (A-3-3) and (A-3-6) is that the type and amount of the tetracarboxylic dianhydride compound and the diamine compound are changed as shown in Tables 1 and 2.

[製備聚醯亞胺化合物][Preparation of Polyimine Compounds] 合成例6Synthesis Example 6

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣,加入式(I-11)之第一二胺化合物(4.44克,0.0075莫耳)(a2-1-1)、式(II-5)之第二二胺化合物(1.16克,0.0025莫耳)(a2-2-1)、對-二胺苯(4.32克,0.04莫耳)(a2-3-1)、及氮-甲基-2-吡咯烷酮(80 克),於室溫下攪拌至溶解。再加入2,3,5-三羧基環戊基醋酸二酐(11.2g,0.05莫耳)(a1-1)及氮-甲基-2-吡咯烷酮(20克),於室溫下反應6小時。之後再加入氮-甲基-2-吡咯烷酮(97克)、乙酸酐(2.55克)及吡啶(19.75克)至該反應溶液中。升溫至60℃持續攪拌2小時進行醯亞胺化,待反應結束後,將該反應液倒入(1500毫升)水中將聚合物析出,過濾所得之聚合物重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚醯亞胺聚合物(A-2-1)。 A nitrogen inlet, a stirrer, a condenser and a thermometer were placed on a four-necked conical flask having a volume of 500 ml, and nitrogen was introduced, and the first diamine compound of the formula (I-11) (4.44 g, 0.0075 mol) was added (a2). -1-1), a second diamine compound of formula (II-5) (1.16 g, 0.0025 mol) (a2-2-1), p-diamine benzene (4.32 g, 0.04 mol) (a2- 3-1), and nitrogen-methyl-2-pyrrolidone (80 (g), stir at room temperature until dissolved. Further, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride (11.2 g, 0.05 mol) (a1-1) and nitrogen-methyl-2-pyrrolidone (20 g) were added and reacted at room temperature for 6 hours. . Then, nitrogen-methyl-2-pyrrolidone (97 g), acetic anhydride (2.55 g) and pyridine (19.75 g) were added to the reaction solution. The mixture was heated to 60 ° C and stirred for 2 hours to carry out hydrazine imidation. After the reaction was completed, the reaction liquid was poured into (1500 ml) water to precipitate a polymer, and the polymer obtained by filtration was repeatedly washed with methanol and filtered three times, and placed. In a vacuum oven, after drying at a temperature of 60 ° C, a polyiminoimine polymer (A-2-1) is obtained.

合成例7至13及合成比較例4及5Synthesis Examples 7 to 13 and Synthesis Comparative Examples 4 and 5

合成例7至13及合成比較例4及5是以與合成例6相同的步驟來製備該聚合物組成物(A-2-2)至(A-2-8),(A-3-4)及(A-3-5)不同的地方在於:改變四羧酸二酐化合物、二胺化合物、催化劑及脫水劑的種類及其用量,如表1及表2所示。 Synthesis Examples 7 to 13 and Synthesis Comparative Examples 4 and 5 were prepared in the same manner as in Synthesis Example 6 (A-2-2) to (A-2-8), (A-3-4). The difference between (A-3-5) and the type of tetracarboxylic dianhydride compound, diamine compound, catalyst and dehydrating agent and their amounts are shown in Tables 1 and 2.

[製備聚矽氧烷][Preparation of polyoxyalkylene] 合成例14Synthesis Example 14

在一容積500毫升的三頸燒瓶中,加入2-縮水甘油醚基乙基三甲氧基矽烷(2-glycidyloxyethyl trimethoxysilane,簡稱為GETMS,0.50莫耳)、二甲基二甲氧基矽烷(dimethyldimethoxysilane,簡稱DMDMS,0.10莫耳)、甲基三甲氧基矽烷(methyltrimethoxysilane,簡稱MTMS,0.40莫耳),如說明書中式(V-6)所示的化合物(簡稱為FPA,0.1mole),及丙二醇單乙基醚(propyleneglycol monoethylether,簡稱PGME,6g)。於室溫下一邊攪拌一邊於30分鐘內添加三乙胺(triethylamine,簡稱TEA)水溶液(20克三乙胺/200克純水)。接著,將燒瓶浸漬於30℃的油浴中並攪拌30分鐘,然後於30分鐘內將油浴升溫至90°C,待溶液的內溫達到75℃時,持續加熱攪拌進行聚縮合6小時。待該聚縮合完成後,將該有機層自該燒瓶中取出並以硝酸銨水溶液(2wt%)清洗,製得該聚矽氧烷(B-1)。 In a 500 ml three-necked flask, 2-glycidyloxyethyl trimethoxysilane (GETMS, 0.50 mol), dimethyldimethoxysilane (dimethyldimethoxysilane, dimethyldimethoxysilane, dimethyldimethoxysilane, dimethyldimethoxysilane, Abbreviated as DMDMS, 0.10 mol), methyltrimethoxysilane (MTMS, 0.40 mol), a compound represented by formula (V-6) in the specification (abbreviated as FPA, 0.1 mole), and propylene glycol monoethyl Propylene glycol Monoethylether, referred to as PGME, 6g). An aqueous solution of triethylamine (TEA) (20 g of triethylamine/200 g of pure water) was added over 30 minutes while stirring at room temperature. Next, the flask was immersed in an oil bath at 30 ° C and stirred for 30 minutes, and then the oil bath was heated to 90 ° C in 30 minutes. When the internal temperature of the solution reached 75 ° C, heating and stirring were continued for polycondensation for 6 hours. After the completion of the polycondensation, the organic layer was taken out from the flask and washed with an aqueous solution of ammonium nitrate (2 wt%) to prepare the polyoxane (B-1).

該第一及第二矽烷化合物、該溶劑、及該催化劑及其用量,及用於製備合成例的反應條件是整理於表3中。 The first and second decane compounds, the solvent, and the catalyst, and the amounts thereof, and the reaction conditions used in the preparation of the synthesis examples are summarized in Table 3.

合成例15至19及合成比較例7及8Synthesis Examples 15 to 19 and Synthesis Comparative Examples 7 and 8

合成例15至19及合成比較例7及8是以與合成例14相同的步驟來製備該聚矽氧烷(B-2)至(B-6)及(B'-1)及(B'-2),不同的地方在於:改變矽烷化合物組份、溶劑及催化劑的種類及其用量,如表3所示。 Synthesis Examples 15 to 19 and Synthesis Comparative Examples 7 and 8 were prepared in the same manner as in Synthesis Example 14 to prepare the polysiloxanes (B-2) to (B-6) and (B'-1) and (B'. -2), the difference is: change the type of decane compound, solvent and catalyst and their dosage, as shown in Table 3.

[液晶配向劑、液晶配向膜及液晶顯示元件的製備][Preparation of Liquid Crystal Aligning Agent, Liquid Crystal Alignment Film, and Liquid Crystal Display Element] 實施例1Example 1

秤取100重量份的合成例1之聚合物組成物、5重量份的合成例14的聚矽氧烷、1200重量份的氮-甲基-2-吡咯烷酮及600重量份的乙二醇正丁基醚,於室溫下攪拌混合形成一液晶配向劑。 100 parts by weight of the polymer composition of Synthesis Example 1, 5 parts by weight of polyfluorene oxide of Synthesis Example 14, 1200 parts by weight of nitrogen-methyl-2-pyrrolidone, and 600 parts by weight of ethylene glycol n-butyl group were weighed. The ether was stirred and mixed at room temperature to form a liquid crystal alignment agent.

將該液晶配向劑以印刷機(日本寫真印刷株式會社製,型號S15-036)分別在兩片具有由ITO(indium-tin-oxide)構成之導電膜的玻璃基板上進行塗佈, 形成一預塗層,之後於加熱板上以溫度100℃、時間5分鐘進行預烤,並在循環烘箱中,以溫度220℃、時間30分鐘進行後烤。在導電膜表面進行配向處理。即可由前述製程使兩玻璃基板分別塗佈有液晶配向膜。 The liquid crystal alignment agent was applied to two glass substrates each having a conductive film made of ITO (indium-tin-oxide) by a printing machine (Model S15-036, manufactured by Nippon Photo Printing Co., Ltd.). A precoat layer was formed, and then prebaked on a hot plate at a temperature of 100 ° C for 5 minutes, and baked in a circulating oven at a temperature of 220 ° C for 30 minutes. The alignment treatment is performed on the surface of the conductive film. The two glass substrates can be respectively coated with a liquid crystal alignment film by the aforementioned process.

接著將前述製得的兩片具有液晶配向膜的玻璃基板,其中一片基板塗以熱壓膠,另一片基板灑上4μm的間隙子(spacer),兩片玻璃順彼此配向垂直方向進行貼合,再以熱壓機施以10kg的壓力,於溫度150℃進行熱壓貼合。然後再以液晶注入機(島津製作所製,型號ALIS-100X-CH)進行液晶注入,利用紫外光(UV)硬化膠封住液晶注入口,以紫外光燈照光使之硬化,並在烘箱中以溫度60℃、時間30分鐘進行液晶回火處理,即可製得一液晶顯示元件。將該液晶配向劑及液晶顯示元件進行各檢測項目評價,所得結果如表4所示。 Then, the two glass substrates having the liquid crystal alignment film prepared as described above are coated with a thermocompression adhesive on one of the substrates, and a spacer of 4 μm is sprinkled on the other substrate, and the two glass sheets are aligned in the vertical direction. Further, a pressure of 10 kg was applied by a hot press, and hot pressing was performed at a temperature of 150 °C. Then, liquid crystal injection is performed by a liquid crystal injection machine (manufactured by Shimadzu Corporation, model ALIS-100X-CH), and the liquid crystal injection port is sealed with ultraviolet light (UV) hardening glue, hardened by ultraviolet light, and dried in an oven. A liquid crystal display element can be obtained by performing liquid crystal tempering treatment at a temperature of 60 ° C for 30 minutes. The liquid crystal alignment agent and the liquid crystal display element were evaluated for each test item, and the results are shown in Table 4.

實施例2至15及比較例1至10Examples 2 to 15 and Comparative Examples 1 to 10

實施例2至15及比較例1至10是以與實施例1相同的步驟來製備該液晶配向劑、液晶配向膜及液晶顯示元件,不同的地方在於:改變聚合物組成物、聚矽氧烷、溶劑及添加劑的種類及其使用量,如表4所示。將該等液晶配向劑及該等液晶顯示元件進行各檢測項目評價,所得結果如表4及5所示。 Examples 2 to 15 and Comparative Examples 1 to 10 were prepared in the same manner as in Example 1 to prepare the liquid crystal alignment agent, the liquid crystal alignment film, and the liquid crystal display element, except that the polymer composition and the polyoxyalkylene were changed. The types of solvents and additives and their use are shown in Table 4. These liquid crystal alignment agents and the liquid crystal display elements were evaluated for each test item, and the results are shown in Tables 4 and 5.

[評價項目][evaluation project]

1、醯亞胺化率: 1, hydrazine imidization rate:

醯亞胺化率係指透過聚醯亞胺聚合物中之醯胺酸官能 基數目和醯亞胺環數目的合計量為基準,計算醯亞胺環數目所佔的比例,以百分率表示。 The imidization rate refers to the proline function in the polyimine polymer. Based on the total number of bases and the number of quinone rings, the ratio of the number of quinone rings is calculated as a percentage.

檢測的方法是將合成例1至13及合成比較例的1至6的聚合物進行減壓乾燥後,溶解於適當的氘化溶劑(deuteration solvent),例如:氘化二甲基亞碸中,以四甲基矽烷作為基準物質,從室溫(例如25℃)下測定1H-NMR(氫原子核磁共振)之結果,再由下式即可求得醯亞胺化率(%)。 The detection method is that the polymers of Synthesis Examples 1 to 13 and the synthetic comparative examples 1 to 6 are dried under reduced pressure, and then dissolved in a suitable deuteration solvent, for example, deuterated dimethyl hydrazine. The results of 1 H-NMR (hydrogen atomic magnetic resonance) were measured from room temperature (for example, 25 ° C) using tetramethyl decane as a reference material, and the sulfhydrylation ratio (%) was determined by the following formula.

醯亞胺化率(%)=[1-△1/(△2×α)]×100 醯 imidization rate (%) = [1-Δ 1 / (△ 2 × α)] × 100

其中△1:NH基團的質子在10ppm附近的化學位移(chemical shift)所產生的峰值(peak)面積;△2:其他質子之峰值面積;及α:聚合物組份中該等聚合物的聚醯胺酸前驅物中NH基的1個質子相對於其他質子個數比例。 Wherein Δ 1 : the peak area of the chemical shift of the proton of the NH group at around 10 ppm; Δ 2 : the peak area of other protons; and α: the polymer of the polymer component The proportion of one proton of the NH group in the polyproline precursor relative to the number of other protons.

2、紫外線可靠度: 2, UV reliability:

離子密度: Ion density:

以電氣測量機台(TOYO Corporation製,型號為Model 6254)分別測量實施例1至15及比較例1至10之液晶顯示元件的離子密度,測試條件是施加1.7伏特電壓、0.01Hz之三角波,於電流-電壓之波形中,計算0至1伏特範圍之波峰面積可測得離子密度(計為ID1);接著將該液晶顯示元件以4200mJ/cm2之紫外光(紫外光照射機型號為KN-SH48K1;光能興業製)照射後,以相同測試條件測量經 紫外光照射後的離子密度(計為ID2)。最後,依下式計算可得離子密度之紫外線可靠度(計為IDUV): The ion density of the liquid crystal display elements of Examples 1 to 15 and Comparative Examples 1 to 10 was measured with an electric measuring machine (manufactured by TOYO Corporation, Model 6254) under the conditions of applying a voltage of 1.7 volts and a triangular wave of 0.01 Hz. In the current-voltage waveform, the ion density (measured as ID1) can be measured by calculating the peak area in the range of 0 to 1 volt; the liquid crystal display element is then irradiated with ultraviolet light of 4200 mJ/cm 2 (the ultraviolet light irradiation model is KN- SH48K1; Light Energy Industrial Co., Ltd.) After irradiation, the ion density after irradiation with ultraviolet light was measured under the same test conditions (calculated as ID2). Finally, the UV reliability of the obtained ion density (calculated as ID UV ) is calculated according to the following formula:

評價基準如下: The evaluation criteria are as follows:

◎:IDUV<5% ◎: ID UV <5%

○:5%≦IDUV<10% ○: 5% ≦ ID UV <10%

△:10%≦IDUV<20% △: 10% ≦ ID UV <20%

╳:IDUV≧20% ╳: ID UV ≧ 20%

電壓保持率: Voltage retention rate:

以電氣測量機台(TOYO Corporation製,型號Modcl 6254)分別測量實施例1至15及比較例1至10之液晶顯示元件的電壓保持率,測試條件是以4伏特電壓歷時2毫秒之施加時間,1667毫秒之跨距施加後,量測施加解除起1667毫秒後之電壓保持率(計為VHR1);接著將該液晶顯示元件以4200mJ/cm2之紫外光(紫外光照射機型號為KN-SH48K1;光能興業製)照射後,以相同測試條件測量經紫外光照射後的電壓保持率(計為VHR2)。最後,依下式計算可得電壓保持率之紫外線可靠度(計為VHRUV): The voltage holding ratios of the liquid crystal display elements of Examples 1 to 15 and Comparative Examples 1 to 10 were respectively measured with an electric measuring machine (manufactured by TOYO Corporation, model Modcl 6254) under the application time of 4 volts for a period of 2 milliseconds. After the span of 1667 milliseconds was applied, the voltage holding ratio (measured as VHR1) after 1667 milliseconds of application cancellation was measured; then the liquid crystal display element was irradiated with ultraviolet light of 4200 mJ/cm 2 (the ultraviolet light irradiation model was KN-SH48K1). After the irradiation, the voltage holding ratio after irradiation with ultraviolet light (calculated as VHR2) was measured under the same test conditions. Finally, calculate the UV reliability of the voltage holding ratio (calculated as VHR UV ) according to the following formula:

評價基準如下: The evaluation criteria are as follows:

◎:VHRUV<5% ◎: VHR UV <5%

○:5%≦VHRUV<10% ○: 5% ≦VHR UV <10%

△:10%≦VHRUV<20% △: 10% ≦VHR UV <20%

╳:VHRUV≧20% ╳: VHR UV ≧ 20%

如表4所示,在實施例1至15中,如式(I)及(II)所示的第一及第二二胺化合物的組合是用於製備該聚合物組成物,且該聚矽氧烷是由將一含有環氧基基團的聚矽氧烷化合物及一具有C4至C50之側鏈的羧酸化合物進行反應所製得。該液晶配向劑具有較佳的紫外線可靠度,且所形成的該液晶配向膜應用於液晶顯示元件時,由於該液晶配向劑同時含有聚合物組成物及聚矽氧烷,該液晶顯示元件在紫外線照射後具有較低的離子密度及較佳的電壓保持率。 As shown in Table 4, in Examples 1 to 15, a combination of the first and second diamine compounds as shown in the formulas (I) and (II) is used for preparing the polymer composition, and the polyfluorene The oxane is obtained by reacting a polyoxyalkylene compound containing an epoxy group and a carboxylic acid compound having a side chain of C 4 to C 50 . The liquid crystal alignment agent has better ultraviolet reliability, and when the liquid crystal alignment film is formed on a liquid crystal display element, since the liquid crystal alignment agent contains a polymer composition and a polyoxyalkylene, the liquid crystal display element is in ultraviolet light. It has a lower ion density and a better voltage holding ratio after irradiation.

如表5所示,由比較例1至6所形成的液晶顯示元件在紫外線照射後具有較高的離子密度及較低的電壓保持率。特別是在比較例1及4中,該等聚合物組成物未使用如式(I)所示的第一二胺化合物來製備。在比較例2中,該聚合物組成物未使用如式(II)所示的第二二胺化合物來製備。在比較例3、5及6中,該等聚合物組成物未使用如式(I)及(II)所示的第一及第二二胺化合物來製備。 As shown in Table 5, the liquid crystal display elements formed by Comparative Examples 1 to 6 had a higher ion density and a lower voltage holding ratio after ultraviolet irradiation. Particularly in Comparative Examples 1 and 4, the polymer compositions were prepared without using the first diamine compound represented by the formula (I). In Comparative Example 2, the polymer composition was not prepared using the second diamine compound represented by the formula (II). In Comparative Examples 3, 5 and 6, the polymer compositions were prepared without using the first and second diamine compounds as shown in the formulae (I) and (II).

在比較例7至10中,本發明所述的聚矽氧烷未使用於製備該液晶配向劑。含有使用該液晶配向劑所製的液晶配向膜的液晶顯示元件在紫外線照射後具有較差的電壓保持率。 In Comparative Examples 7 to 10, the polyoxyalkylene described in the present invention was not used in the preparation of the liquid crystal alignment agent. A liquid crystal display element containing a liquid crystal alignment film produced using the liquid crystal alignment agent has a poor voltage holding ratio after ultraviolet irradiation.

此外,當該聚合物組成物的醯亞胺化率為30%至90%,由該液晶配向劑所形成的該液晶配向膜應用於液晶顯示元件時,該液晶顯示元件在紫外線照射後具有較低的離子密度。並且,當使用由含有環氧基基團的聚矽氧烷 化合物及具有C6至C50之側鏈的羧酸化合物進行反應所製得的聚矽氧烷,含有該液晶配向膜的液晶顯示元件在紫外線照射後具有較佳的電壓保持率。 Further, when the sulfonium imidization ratio of the polymer composition is 30% to 90%, when the liquid crystal alignment film formed of the liquid crystal alignment agent is applied to a liquid crystal display element, the liquid crystal display element has a higher after ultraviolet irradiation Low ion density. Further, when a polysiloxane having a polyoxyalkylene compound containing an epoxy group and a carboxylic acid compound having a side chain of C 6 to C 50 is used, a liquid crystal display containing the liquid crystal alignment film is used. The component has a better voltage holding ratio after ultraviolet irradiation.

綜上所述,在本發明中,該液晶配向膜具有較佳的紫外線可靠度,是由含有使用由式(I)及(II)表示的第一及第二二胺化合物進行反應所製得的聚合物組成物,以及由將一含有環氧基基團的聚矽氧烷化合物及一具有C4至C50之側鏈的羧酸化合物進行反應所製得的聚矽氧烷的液晶配向劑所形成。並且,含有該液晶配向膜的該液晶顯示元件在照射紫外線後具有較低的離子密度及較佳的電壓保持率,故確實能達成本發明之目的。 In summary, in the present invention, the liquid crystal alignment film has a preferable ultraviolet ray reliability and is obtained by reacting the first and second diamine compounds represented by the formulas (I) and (II). Polymer composition, and liquid crystal alignment of polyoxyalkylene obtained by reacting a polyoxyalkylene compound containing an epoxy group and a carboxylic acid compound having a C 4 to C 50 side chain The agent is formed. Further, since the liquid crystal display element including the liquid crystal alignment film has a low ion density and a preferable voltage holding ratio after irradiation with ultraviolet rays, the object of the present invention can be surely achieved.

惟以上所述者,僅為本發明之較佳實施例而已,當不能以此限定本發明實施之範圍,即大凡依本發明申請專利範圍及專利說明書內容所作之簡單的等效變化與修飾,皆仍屬本發明專利涵蓋之範圍內。 The above is only the preferred embodiment of the present invention, and the scope of the present invention is not limited thereto, that is, the simple equivalent changes and modifications made by the patent application scope and patent specification content of the present invention, All remain within the scope of the invention patent.

11‧‧‧第一單元 11‧‧‧ first unit

111‧‧‧第一基板 111‧‧‧First substrate

112‧‧‧第一導電膜 112‧‧‧First conductive film

113‧‧‧第一液晶配向膜 113‧‧‧First liquid crystal alignment film

12‧‧‧第二單元 12‧‧‧Second unit

121‧‧‧第二基板 121‧‧‧second substrate

122‧‧‧第二導電膜 122‧‧‧Second conductive film

123‧‧‧第二液晶配向膜 123‧‧‧Second liquid crystal alignment film

13‧‧‧液晶單元 13‧‧‧Liquid Crystal Unit

Claims (9)

一種液晶配向劑,包含:一聚合物組成物是由將四羧酸二酐組份及二胺組份進行反應所製得;一聚矽氧烷,及一溶劑;其中,該二胺組份包括一式(I)所示的第一二胺化合物: 其中 R12及R14是獨立地選自於-O-、-S-、 R13表示一C2至C10的亞烷基,R11是選自於單鍵、亞甲基、伸乙基,及X表示一C17至C40具有膽固醇骨架的一價有機基團;一式(II)所示的第二二胺化合物: 其中 R15是選自於-O-、 R16表示一如式(II-1)所示的有機基團: 其中R17是獨立地表示氫、氟或甲基;R18、R19或R20各 自獨立地表示單鍵、-O-、或C1至C3的伸烷基; R21是獨立地選自於,其中R23及R24各自獨立地表示氫、氟或甲基,R22是選自於氫、氟、C1至C12的烷基、C1至C12的氟烷基、C1至C12的烷氧基、-OCH2F、-OCHF2或-OCF3;k表示1或2的整數,l、m及n是各自獨立地表示0至4的整數,o、p及q是各自獨立地表示0至3的整數,且條件是o+p+q≧3,及r及s是各自獨立地表示1或2;其中該聚矽氧烷是由將一含有環氧基基團的聚矽氧烷化合物及一具有C4至C50之側鏈的羧酸化合物進行反應所製得。 A liquid crystal alignment agent comprising: a polymer composition obtained by reacting a tetracarboxylic dianhydride component and a diamine component; a polyoxyalkylene oxide; and a solvent; wherein the diamine component The first diamine compound represented by the formula (I) is included: Wherein R 12 and R 14 are independently selected from -O-, -S-, , R 13 represents a C 2 to C 10 alkylene group, R 11 is a monovalent organic group selected from the group consisting of a single bond, a methylene group, an extended ethyl group, and X represents a C 17 to C 40 having a cholesterol skeleton; a second diamine compound of formula (II): Wherein R 15 is selected from -O-, , , , R 16 represents an organic group as shown in the formula (II-1): Wherein R 17 is independently hydrogen, fluoro or methyl; and R 18 , R 19 or R 20 each independently represents a single bond, -O-, , , , , Or a C 1 to C 3 alkylene group; R 21 is independently selected from and Wherein R 23 and R 24 each independently represent hydrogen, fluorine or methyl, and R 22 is selected from the group consisting of hydrogen, fluorine, C 1 to C 12 alkyl, C 1 to C 12 fluoroalkyl, C 1 to Alkoxy group of C 12 , -OCH 2 F, -OCHF 2 or -OCF 3 ; k represents an integer of 1 or 2, and l, m and n are integers each independently representing 0 to 4, and o, p and q are Each independently represents an integer from 0 to 3, and the condition is o+p+q≧3, and r and s each independently represent 1 or 2; wherein the polyoxyalkylene is composed of an epoxy group-containing group The polyoxyalkylene compound is obtained by reacting a carboxylic acid compound having a side chain of C 4 to C 50 . 如請求項1所述的液晶配向劑,其中,該含有環氧基基團的聚矽氧烷化合物是由一矽烷化合物組份聚縮合而形成,該矽烷化合物組份包含一如式(III)所示的第一矽烷化合物:Si(R32)y(OR33)4-y (III)其中至少一的R32是選自於式(B-1)、式(B-2)或式(B-3)的官能基,其餘的R32是獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R33是各自獨立地選自於氫原子、C1至C6的烷基、C1至C6的醯基,或C6至C15的芳基,及Y表示1至3的整數; 其中A是選自於氧原子或單鍵,h是表示由1至3的整數,及i是表示由0至6的整數,且條件是當i為0時A表示一單鍵, 其中j是表示由0至6的整數, 其中B1是表示C2至C6之伸烷基;R34表示氫原子或C1至C6之烷基。 The liquid crystal alignment agent according to claim 1, wherein the epoxy group-containing polyoxyalkylene compound is formed by polycondensation of a monodecane compound component, wherein the decane compound component comprises a formula (III) The first decane compound shown: Si(R 32 ) y (OR 33 ) 4-y (III) wherein at least one of R 32 is selected from the group consisting of formula (B-1), formula (B-2) or formula ( a functional group of B-3), the remaining R 32 being independently selected from a hydrogen atom, a C 1 to C 10 alkyl group, a C 2 to C 10 alkenyl group, and a C 6 to C 15 aryl group, R 33 is an aryl group each independently selected from a hydrogen atom, a C 1 to C 6 alkyl group, a C 1 to C 6 fluorenyl group, or a C 6 to C 15 aryl group, and Y represents an integer of 1 to 3; Wherein A is selected from an oxygen atom or a single bond, h is an integer representing from 1 to 3, and i is an integer representing from 0 to 6, and the condition is that when i is 0, A represents a single bond, Where j is an integer representing from 0 to 6, Wherein B 1 is an alkylene group representing C 2 to C 6 ; R 34 represents a hydrogen atom or an alkyl group of C 1 to C 6 . 如請求項2所述的液晶配向劑,其中,該矽烷化合物還包含一如式(IV)所示的第二矽烷化合物:Si(R35)b(OR36)4-b (IV)其中R35是獨立地選自於氫原子、C1至C10的烷基、C2至C10的烯基,及C6至C15的芳基,R36是各自獨立地選自於氫原子、C1至C6的烷基、C1至C6的醯基,或C6至C15的芳基,及b表示0至3的整數。 The liquid crystal alignment agent according to claim 2, wherein the decane compound further comprises a second decane compound represented by the formula (IV): Si(R 35 ) b (OR 36 ) 4-b (IV) wherein R 35 is independently selected from a hydrogen atom, C 1 to C 10 alkyl group, the C 2 to C 10 alkenyl groups, and aryl groups and C 6 to C 15 a, R 36 are each independently selected from a hydrogen atom, C 1 to C 6 alkyl, and C 1 to C 6 acyl or C 6 to C 15 aryl group, and and b represents an integer of 0 to 3. 如請求項1所述的液晶配向劑,其中,該羧酸化合物具有C6至C50之側鏈。 The requested item of the liquid crystal alignment agent, wherein the carboxylic acid compound having a C 6 to C 50 of the side chain. 如請求項1所述的液晶配向劑,其中,基於該矽烷化合物組份的總用量為100莫耳,式(I)所示的該第一二胺化合物的使用量範圍為5至25莫耳,且式(II)所示的該第二二胺化合物的使用量範圍為5至25莫耳。 The liquid crystal alignment agent according to claim 1, wherein the first diamine compound represented by the formula (I) is used in an amount ranging from 5 to 25 mols, based on the total amount of the decane compound component being 100 mol. And the second diamine compound represented by the formula (II) is used in an amount ranging from 5 to 25 mols. 如請求項1所述的液晶配向劑,其中,該聚合物組成物的醯亞胺化率範圍為30至90%。 The liquid crystal alignment agent according to claim 1, wherein the polymer composition has a oxime imidization ratio ranging from 30 to 90%. 如請求項1所述的液晶配向劑,其中,基於聚合物組成物為100重量份,該聚矽氧烷的使用量為3至30重量份,該溶劑的使用量為500至3000重量份。 The liquid crystal alignment agent according to claim 1, wherein the polysiloxane is used in an amount of from 3 to 30 parts by weight based on 100 parts by weight of the polymer composition, and the solvent is used in an amount of from 500 to 3,000 parts by weight. 一種液晶配向膜,是由一如請求項第1至7項中任一項 所述的液晶配向劑所形成。 A liquid crystal alignment film is provided by any one of claims 1 to 7 The liquid crystal alignment agent is formed. 一種液晶顯示元件,是包含一如請求項第8項所述的液晶配向膜。 A liquid crystal display element comprising the liquid crystal alignment film of claim 8.
TW104107577A 2015-03-10 2015-03-10 Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent TWI563036B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW104107577A TWI563036B (en) 2015-03-10 2015-03-10 Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
CN201610133685.6A CN105969404B (en) 2015-03-10 2016-03-09 Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104107577A TWI563036B (en) 2015-03-10 2015-03-10 Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent

Publications (2)

Publication Number Publication Date
TW201632585A true TW201632585A (en) 2016-09-16
TWI563036B TWI563036B (en) 2016-12-21

Family

ID=56989027

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104107577A TWI563036B (en) 2015-03-10 2015-03-10 Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent

Country Status (2)

Country Link
CN (1) CN105969404B (en)
TW (1) TWI563036B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI649351B (en) * 2016-10-31 2019-02-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI760357B (en) * 2017-08-24 2022-04-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI679217B (en) * 2018-03-02 2019-12-11 達興材料股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TWI768301B (en) 2020-03-10 2022-06-21 達興材料股份有限公司 Diamine, method of preparing a diamine, and application of a diamine
CN114507149A (en) * 2020-11-16 2022-05-17 奇美实业股份有限公司 Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105892A1 (en) * 2004-04-28 2005-11-10 Nissan Chemical Industries, Ltd. Liquid-crystal aligning agent, liquid-crystal alignment film comprising the same, and liquid-crystal element
JP5454772B2 (en) * 2008-11-17 2014-03-26 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film, method for forming the same, and liquid crystal display element
TWI455961B (en) * 2012-04-24 2014-10-11 Chi Mei Corp Liquid crystal alignment agent, liquid crystal alignment film and liguid crystal display element
TWI520985B (en) * 2012-07-18 2016-02-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liguid crystal display element
TWI522392B (en) * 2013-05-22 2016-02-21 奇美實業股份有限公司 Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof

Also Published As

Publication number Publication date
CN105969404A (en) 2016-09-28
CN105969404B (en) 2018-03-23
TWI563036B (en) 2016-12-21

Similar Documents

Publication Publication Date Title
KR101730297B1 (en) Liquid crystal aligning agent, process for forming liquid crystal aligning film, liquid crystal display device, and polyorganosiloxane
TWI460509B (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
KR101778091B1 (en) Liquid crystal aligning agent, method for forming liquid crystal alignment film and liquid crystal display device
TWI458708B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
KR101536009B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR101679235B1 (en) Process for producing liquid crystal display device, liquid crystal display device produced thereby and related compositions
JP5668931B2 (en) Liquid crystal alignment agent
KR102018163B1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display device and menufacturing method thereof
TWI406931B (en) Liquid crystal aligning agent and liquid crystal alignment film
KR102030401B1 (en) Liquid crystal aligning agent for psa mode liquid crystal display device, liquid crystal alignment film for psa mode liquid crystal display device, and the psa mode liquid crystal display device and manufacturing method thereof
TW201632585A (en) Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
TWI537337B (en) Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
TWI653494B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101765504B1 (en) Liquid crystal aligning agent and liquid crystal display device
TWI537338B (en) Liquid crystal alignment agent and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent
TW201811864A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
JP5767800B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI644947B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201903049A (en) Liquid crystal alignment agent, method for producing liquid crystal alignment film, and liquid crystal display element
TWI760357B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI671358B (en) Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element and production method thereof
JP5041599B2 (en) Liquid crystal aligning agent, liquid crystal aligning film, formation method thereof, liquid crystal display element and optical member
JP2018032029A (en) Liquid crystal aligning agent and production method of the same
TW201930468A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI773684B (en) Liquid crystal alignment agent, production method of liquid crystal alignment film and liquid crystal display element

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees